Martin Eklund
Professor
E-mail: martin.eklund@ki.se
Telephone: +46852482501
Mobile phone: +46737121611
Visiting address: Nobels väg 12a, 17165 Solna
Postal address: C8 Medicinsk epidemiologi och biostatistik, C8 MEB Eklund, 171 77 Stockholm
Part of:
- Department of Medical Epidemiology and Biostatistics
- Martin Eklund's research group
About me
- I am professor of epidemiology at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet (KI). I did all my undergraduate studies at Uppsala University, apart from a three-semester stint at the University of Otago in Dunedin, New Zealand, where I studied mathematics and biotechnology. I also did my PhD at Uppsala University, mainly focusing on computer intensive methods for statistical model choice and validation.
After finishing my PhD, I moved on to postdoc positions at the section for Global Safety Assessment at AstraZeneca and at the Department of Medical Epidemiology and Biostatistics, KI. During 2013 and 2014, I was based in San Francisco and worked at the Department of Surgery, University of California San Francisco (UCSF).
Since 2015, I am based at MEB where I focus my research on reducing the mortality of breast- and prostate cancer as well as the negative side effects of today’s imprecise diagnostics and treatment selection. To achieve this, I have together with a fantastic team of national and international colleagues, coworkers, and collaborators constructed research programs spanning across biomarker development, validation and implementation, prediction modeling and artificial intelligence, translational medicine, and clinical trials.
Research
- My research aims to reduce breast- and prostate cancer mortality through the use of individualized prevention, diagnostics, and treatment.
=== Prostate cancer ===
Stockholm3
The prostate-specific antigen (PSA) test is used to screen for prostate cancer but has a high false-positive rate that translates into unnecessary prostate biopsies and overdiagnosis of low-risk prostate cancers. STHLM3 (sthlm3.se) was a large-scale prospective and population-based prostate cancer diagnostic trial involving close to 60, 000 men in Stockholm 2013-2015 with the aim of to develop and validate a model to identify high-risk prostate cancer with better test characteristics. The two screening methods, PSA and the Stockholm3 test, were assessed and compared for safety and efficacy. The primary aim of the STHLM3 trial was to investigate if the Stockholm3 test could substantially reduce the proportion of men undergoing prostate biopsy whilst maintaining the sensitivity for detecting consequential prostate cancer (Gleason Score 7 or above) compared to PSA. The results showed that the Stockholm3 test could reduce the number of unnecessary prostate biopsies by close to 50% and decrease indolent cancers (Gleason 6, typically regarded as overdiagnosed cancers) by 20%, without reducing the sensitivity to detect consequential prostate cancer compared to using the PSA. The data from the trial provides a fantastic resource for studying prostate cancer diagnostics, and has since the publication of the main results in the Lancet Oncology 2015 been used in a large number of follow-up publications.
Stockholm3-MRI
We are currently conducting the STHLM3-MRI trials (NCT03377881). That MRI improves prostate cancer diagnostics has become clear over the last few years. During 2016 and 2017, we performed the “STHLM3 MRI Phase 1 – A paired diagnostic trial”, where we included 723 men referred for a prostate biopsy at six centra (4 in Stockholm and 2 in Norway). Stockholm-3 combined with MRI was shown to decrease both unnecessary biopsies and overdiagnosis by about 50% and at the same time increase the sensitivity for consequential prostate cancer (Gleason score ≥ 7) compared to using systematic biopsies on all men. The second stage of the STHLM3-MRI research program was conducted 2018-2020, where we assessed the combined use of risk prediction using the Stockholm3 test together with MRI and targeted biopsies in a large-scale (N=12, 750) prospective and population-based randomized screening-by-invitation setting. The aims of the trial was to shown improved specificity and reduced detection of clinically insignificant disease in early detection of prostate cancer without decreasing the sensitivity of clinically significant prostate cancers by combining the Stockholm-3 prediction model together with MRI and targeted prostate biopsies. The first papers from this trial were published in NEJM and the Lancet Oncology, respectively. In these manuscripts, we show that MRI with targeted and standard biopsy in MRI-positive men was noninferior to standard biopsy for detecting clinically significant prostate cancer, and markedly reduced detection of clinically insignificant cancer. The reduced rates of unnecessary biopsy and diagnosis of clinically insignificant cancer address key barriers impeding implementation of population-based screening for prostate cancer. We further demonstrated that the Stockholm3 prostate test can inform risk stratification before MRI and targeted biopsies in prostate cancer screening.
AI assisted prostate cancer pathology
Histopathological evaluation of prostate biopsies is critical to the clinical management of men suspected of having prostate cancer. Despite this importance, the histopathological diagnosis of prostate cancer is associated with a number of challenges: The large number of prostate biopsies being performed worldwide together with the shortage of well-trained uro-pathologists and the high inter- pathologist variability leads to suboptimal prostate cancer diagnostics and prognostication, with risks for under- and overtreatment. We have over the last years developed an artificial intelligence (AI) system to assist the pathologists in the evaluation of prostate biopsies, with the overarching aim of solving these problems. In articles published in the Lancet Oncology in 2020 and Nature Medicine 2022, we demonstrate that the system performs on par with internationally leading uro-pathologist for grading prostate needle biopsies. We are now working on further developing the AI system, in particular by:
1. Performing retrospective international multisite validation of the AI system to assess and improve the AI’s performance across different labs, technical platforms, and disease subtypes
2. Developing methods to go beyond today’s grading to improve prognostication
3. Linking the AI system with genomic profiling of tumor tissue to improve treatment selection
4. Performing prospective validation of the AI system in a randomized diagnostic histopathology trial (scheduled to start early 2024).
STHLM3-AS
Conservative management with active surveillance of men diagnosed with low-risk prostate cancer includes serial testing with PSA tests and systematic prostate biopsies for disease progression to offer selective delayed treatment with curative intent. A drawback with current active surveillance is the large number of prostate biopsies the men undergo, which leads to reduced adherence to follow-up biopsies with the risk of missing the curative window of progressing disease. In addition, biopsies increase the risk of severe infections. The objective of the prospective STHLM3-AS trial was to assess a less invasive and more cost-effective way to detect clinical significant prostate cancer in men on active surveillance including an improved blood-based Stockholm3 test for identification of men with increased risk of upgraded prostate cancer and use of MRI to select men for diagnostic workup with targeted prostate biopsies. The main results from the trial was published in JNCI in 2021.
ProBio
Approximately 30% of men diagnosed with prostate cancer develop lethal metastatic castration-resistant prostate cancer (mCRPC). Although recently approved new drugs are beneficial for many mCRPC patients they carry three serious disadvantages. First, these drugs are all very expensive. Second, the response rates to these drugs are low, ranging between 20-40%. This leads to suboptimal treatment and unnecessary side-effects. Third, there are no predictive treatment markers available in clinical care today, which leads to ineffective trial-and-error in treatment decisions. Our hypothesis is that treatment decisions based on molecular profiling will significantly increase progression free survival compared to current clinical care. The vast majority of CRPC metastasize to the bone, with low success rate in obtaining sufficient material. Therefore, we sequence circulating tumor DNA (ctDNA) consisting of DNA debris from apoptotic cancer being present at high levels in plasma. We are currently testing this hypothesis in the ProBio trial, a large, international, multicentre, randomized study in men with mCRPC that started in 2018. ProBio (NCT03903835) uses an outcome-adaptive randomization trial design, with the goal to learn as rapidly as possible which treatments are effective for which ctDNA biomarker profiles. We are currently working on extending the ProBio platform trial to also encompass men with metastatic hormone sensitive prostate cancer (mHSPC). The design and objectives of the ProBio trial have been described in a publication in Trials in 2020.
=== Breast cancer ===
The WISDOM trial
The WISDOM trial (wisdomstudy.org) investigates whether a risk-based approach to breast cancer screening is as safe and effective as annual mammograms. We will also determine whether women readily accept personalized screening and if knowledge of their own risks, and the reasons for less-frequent screening, will reduce anxiety about breast cancer. Finally, we will determine whether our personalized approach will lead to more of the highest-risk women deciding to use strategies that can prevent breast cancer. Participants in the personalized screening arm receive a risk assessment that includes family and medical history, breast density measurement, and genomic tests (SNPs and high-penetrance genes such as BRCA1/2). WISDOM is currently enrolling and will in total enroll 65, 000 women across sites covering the entire US. WISDOM is funded by the Patient Centered Research Outcomes Institute (PCORI) and NIH. We have described the design and objectives of WISDOM in a string of publications (see e.g. JNCI and JNCI Cancer Spectrum).
KARISMA
The KARISMA trial was a six-armed randomized, double-blinded, placebo controlled study that started in November 2016 and finished in 2020 to investigate the effectiveness of different doses of Tamoxifen to reduce mammography density, with the aim of improving breast cancer prevention. The purpose of KARISMA is to identify the lowest dose of Tamoxifen being within the equivalence limits of 20 mg Tamoxifen arm and to determine dose dependent adverse events and quality of life. Our hypothesis was that a lower dose of Tamoxifen has non-inferior ability to prevent breast cancer as a 20 mg dose, but results is markedly less side effects and is therefore more readily acceptable by women. The main results from the trial was published in JCO in 2021, and several follow-up manuscripts are currently being written.
=== Other diseases and conditions ===
COVID
The goal of the I-SPY COVID trial is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2, open label, randomised platform design, we aim to identify agents with a signal suggesting a big impact on reducing mortality and the need for, as well as duration, of mechanical ventilation. There are numerous potential effective therapies that warrant testing in clinical trials. Although several therapies are under investigation, each trial is a one-off effort, many are not randomized, and there is no coordinated rapid cycle learning. An adaptive platform trial is the ideal design, as it allows the rapid screening of many agents simultaneously. The study design features comparison of investigational agent efficacy using a Bayesian design against current standard of care (including remdesivir+dexamethasone as backbone therapy). The trial started in July 2020 and is accruing patients across 35 sites in the United States. The trial rationale is described in a recent publication in Nature Medicine.
Proximal hamstrings avulsions
PHACT is an international, prospective, multicentre, randomized controlled trial comparing operative to nonoperative treatment of proximal hamstrings avulsions. The aim of PHACT is to obtain reliable evidence for the effectiveness of the two basic treatment options (surgical versus non-surgical treatment) for patients with total proximal hamstrings avulsions. Our primary aim is to compare the patient reported functional outcome, as measured by the Perth hamstrings assessment tool (PHAT), of surgically treated hamstrings avulsions compared to non-operative treated ruptures. The primary outcomes of the study are the PHAT scores 24 months.
=== Group members ===
Nita Mulliqi (PhD student)
Hari Vigneswaran (PhD student)
Kelvin Szolnoky (PhD student)
Joel Andersson (PhD student)
Xiaoyi Ji (PhD student)
Chiara Micoli (PhD student)
Kimmo Kartasalo (postdoc)
Henrik Olsson (postdoc)
Alessio Crippa (senior research specialist)
Thorgerdur Palsdottir (postdoc)
Andrea Discacciati (statistician)
Vivekananda Lanka (database developer)
Geraldine Martinez Gonzalez (research assistant)
Previous group members
Matteo Titus (research assistant)
Álvaro Fernández Quílez (postdoc, now at Stavanger University Hospital, Norway)
Peter Ström (PhD student, graduated 2020. Now doing AI development in industry)
Anna Lantz (postdoc, now independent PI)
Andreas Karlsson (postdoc, now doing AI development in industry)
Weronika Wrzos-Kaminska (research assistant, now PhD student at EPFL, Switzerland)
=== Current research grants (as PI) ===
My research is supported by the Swedish Research Council (Vetenskapsrådet), the Swedish Research Council for Health, Working Life and Welfare (FORTE), the Swedish Cancer Society (Cancerfonden), Karolinska Institutet, the European Institute of Innovation & Technology (EIT), Prostatacancerförbundet, Åke Wiberg Foundation, the Stockholm County Council (SLL), the Nordic Cancer Union (NCU), the Patient Centered Research Outcome Institutet (PCORI), and the National Institutet for Health (NIH).
Teaching
- I currently teach the course “Multivariable prediction modeling with applications in precision medicine” (LK2990) together with Mattias Rantalainen. In a collaboration Mieke Van Hemelrijck at King's College London, I am also responsible for the course "Clinical Cancer Epidemiology: From Prevention to Treatment and Patient Care".
Selected publications
- Article: NEW ENGLAND JOURNAL OF MEDICINE. 2025;393(11):1051-1064Martling A; Hed Myrberg I; Nilbert M; Grönberg H; Granath F; Eklund M; Öresland T; Iversen LH; Haapamäki C; Janson M; Westberg K; Segelman J; Ersson U; Prytz M; Angenete E; Bergström R; Mayrhofer M; Glimelius B; Lindberg J; ALASCCA Study Group
- Article: NATURE MEDICINE. 2022;28(1):154-163Bulten W; Kartasalo K; Chen P-HC; Strom P; Pinckaers H; Nagpal K; Cai Y; Steiner DF; van Boven H; Vink R; Hulsbergen-van de Kaa C; van der Laak J; Amin MB; Evans AJ; van der Kwast T; Allan R; Humphrey PA; Gronberg H; Samaratunga H; Delahunt B; Tsuzuki T; Hakkinen T; Egevad L; Demkin M; Dane S; Tan F; Valkonen M; Corrado GS; Peng L; Mermel CH; Ruusuvuori P; Litjens G; Eklund M
- Article: NEW ENGLAND JOURNAL OF MEDICINE. 2021;385(10):908-920Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Groenberg H; Nordstroem T
- Article: LANCET ONCOLOGY. 2021;22(9):1240-1249Nordstrom T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(17):1899-1908Eriksson M; Eklund M; Borgquist S; Hellgren R; Margolin S; Thoren L; Rosendahl A; Lang K; Tapia J; Backlund M; Discacciati A; Crippa A; Gabrielson M; Hammarstrom M; Wengstrom Y; Czene K; Hall AP
- Article: JAMA ONCOLOGY. 2020;6(10):1581-1588Salim M; Wahlin E; Dembrower K; Azavedo E; Foukakis T; Liu Y; Smith K; Eklund M; Strand F
- Article: LANCET ONCOLOGY. 2020;21(2):222-232Strom P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wahlby C; Gronberg H; Rantalainen M; Egevad L; Eklund M
- Article: JNCI CANCER SPECTRUM. 2018;2(4):pky067Eklund M; Broglio K; Yau C; Connor JT; Fiscalini AS; Esserman LJ
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2017;109(5):djw290Shieh Y; Eklund M; Madlensky L; Sawyer SD; Thompson CK; Fiscalini AS; Ziv E; van't Veer LJ; Esserman LJ; Tice JA
- Review: NATURE REVIEWS CLINICAL ONCOLOGY. 2016;13(9):550-565Shieh Y; Eklund M; Sawaya GF; Black WC; Kramer BS; Esserman LJ
- Article: LANCET ONCOLOGY. 2015;16(16):1667-1676Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Articles
- Article: MEDICAL IMAGE ANALYSIS. 2025;105:103663Grisi C; Kartasalo K; Eklund M; Egevad L; van der Laak J; Litjens G
- Journal article: GENOME MEDICINE. 2025;17(1):97Fergus KB; Heise RS; Madlensky L; Fiscalini A; Sabacan L; Theiner S; Kapoor S; Soto IA; Blanco A; Ross K; Goodman-Gruen D; Scheuner M; Hu D; Heditsian D; Brain S; Arasu VA; Kaster A; Chapa L; Olopade OI; Eklund M; Tice JA; Ziv E; van 't Veer L; Esserman LJ; Shieh Y
- Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 2025;393(8):831-832Eklund M; Thompson IM; Cooperberg MR
- Article: CANCER. 2025;131(16):e70045Falagario UG; Pellegrino F; Abbadi A; Bjornebo L; Valdman A; Eriksson MH; Zelic R; Carrieri G; Gandaglia G; Briganti A; Montorsi F; Aly M; Palsdottir T; Eklund M; Nordstrom T; Gronberg H; Akre O; Wiklund P; Lantz A
- Journal article: JOURNAL OF UROLOGY. 2025;214(2):238Lazarovich A; Vigneswaran H; Palsdottir T; Eklund M; Discacciati A; Nordstrom T; Hubbard RA; Perlis N; Abern MR; Moreira DM; Yonover P; Chow AK; Watts K; Liss MA; Thoreson GR; Abreu AL; Sonn GA; Plym A; Wiklund F; Gronberg H; Murphy AB; Eggener S
- Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(4):1070-1077Skalt D; Chen T; Abbadi A; Lantz A; Discacciati A; Eklund M; Clements M; Nordstrom T; Hao S
- Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(4):1078-1086Falagario UG; Pellegrino F; Björnebo L; Abbadi A; Martini A; Valdman A; Conteduca V; Carrieri G; Gandaglia G; Briganti A; Montorsi F; Palsdottir T; Eklund M; Nordström T; Grönberg H; Aly M; Tewari A; Akre O; Lantz A; Wiklund P
- Article: EUROPEAN UROLOGY FOCUS. 2025;:S2405-4569(25)00175-0Björnebo L; Discacciati A; Abbadi A; Falagario UG; Engel JC; Vigneswaran HT; Jäderling F; Grönberg H; Eklund M; Lantz A; Nordström T
- Article: JOURNAL OF CLINICAL PATHOLOGY. 2025;78(6):429-431Egevad L; Micoli C; Delahunt B; Samaratunga H; Garmo H; Stattin P; Eklund M
- Journal article: JOURNAL OF UROLOGY. 2025;213(5S):e687Vigneswaran H; Palsdottir T; Micoli C; Tilki D; Lin D; Cooperberg M; Eggener S; Moller A; Aly M; Akre O; Wiklund P; Egevad L; Gronberg H; Nordstrom T; Eklund M
- Journal article: JOURNAL OF UROLOGY. 2025;213(5S):e155Lazarovich A; Vigneswaran H; Palsdottir T; Eklund M; Discacciati A; Nordstrom T; Hubbard RA; Perlis N; Abern MR; Moreira DM; Yonover P; Chow AK; Watts K; Liss MA; Thoreson GR; Labreu A; Sonn GA; Plym A; Wiklund F; Gronberg H; Murphy AB; Eggener S
- Journal article: JOURNAL OF UROLOGY. 2025;213(5S):e1232Giudici N; Scuderi S; Palsdottir T; Nordstrom T; Eklund M; Jensby EF; Borre M; Pedersen BG; Gronberg H; Sorensen KD; Kjosavik SR; Lantz A
- Article: JOURNAL OF UROLOGY. 2025;213(5):590-599Lazarovich A; Vigneswaran H; Palsdottir T; Eklund M; Discacciati A; Nordstrom T; Hubbard RA; Perlis N; Abern MR; Moreira DM; Yonover P; Chow AK; Watts K; Liss MA; Thoreson GR; Abreu AL; Sonn GA; Plym A; Wiklund F; Gronberg H; Murphy AB; Eggener S
- Article: MODERN PATHOLOGY. 2025;38(5):100715Ji X; Salmon R; Mulliqi N; Khan U; Wang Y; Blilie A; Olsson H; Pedersen BG; Sorensen KD; Ulhoi BP; Kjosavik SR; Janssen EAM; Rantalainen M; Egevad L; Ruusuvuori P; Eklund M; Kartasalo K
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2025;54(3):dyaf062Abbadi A; Eklund M; Aly M; Clements M; Crippa A; Discacciati A; Bjorklund A; Lanka V; Micoli C; Lantz A; Gronberg H; Nordstrom T
- Article: ECLINICALMEDICINE. 2025;82:103191Abbadi A; Eklund M; Lantz A; Discacciati A; Bjornebo L; Palsdottir T; Engel JC; Jaderling F; Falagario U; Gronberg H; Nordstrom T
- Journal article: ECLINICALMEDICINE. 2025;82:103191Abbadi A; Eklund M; Lantz A; Discacciati A; Björnebo L; Palsdottir T; Chandra Engel J; Jäderling F; Falagario U; Grönberg H; Nordström T
- Article: PATHOLOGY. 2025;57(3):293-296Egevad L; Micoli C; Delahunt B; Samaratunga H; Garmo H; Stattin P; Eklund M
- Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(2):435-443Engel JC; Eklund M; Jaderling F; Palsdottir T; Falagario U; Discacciati A; Nordstrom T
- Article: CHEST CRITICAL CARE. 2025;3(1):100117Mabrey FL; Martin TR; Calfee CS; Liu KD; LaCombe B; Brown-Swigart L; Discacciati A; Eklund M; Heckbert SR; Matthay MA; Esserman L; Wurfel MM
- Journal article: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2025;43(3):76Lazarovich A; Vigneswaran H; Palsdottir T; Eklund M; Discacciati A; Nordström T; Hubbard R; Perlis N; Abern M; Moreira D; Yonover P; Chow A; Watts K; Liss M; Thoreson G; Abreu A; Sonn G; Plym A; Wiklund F; Grönberg H; Murphy A; Eggener S
- Article: RADIOLOGY. 2025;314(3):e242566Dembrower KE; Crippa A; Eklund M; Strand F
- Article: BMJ OPEN. 2025;15(2):e089428Badal K; Staib J; Tice JA; Kim M-O; Eklund M; Wilson L; Byfield SD; Catlett K; Maffey L; Soonavala R; Shieh Y; Esserman LJ
- Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(1):80-86Du X; Hao S; Olsson H; Kartasalo K; Mulliqi N; Rai B; Menges D; Heintz E; Egevad L; Eklund M; Clements M
- Article: EUROPEAN UROLOGY ONCOLOGY. 2024;:S2588-9311(24)00244-XDiscacciati A; Abbadi A; Clements MS; Annerstedt M; Carlsson S; Grönberg H; Jäderling F; Eklund M; Nordström T
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(32):3806-3816Vigneswaran HT; Eklund M; Discacciati A; Nordstrom T; Hubbard RA; Perlis N; Abern MR; Moreira DM; Eggener S; Yonover P; Chow AK; Watts K; Liss MA; Thoreson GR; Abreu AL; Sonn GA; Palsdottir T; Plym A; Wiklund F; Gronberg H; Murphy AB
- Article: NATURE MEDICINE. 2024;30(11):3291-3302De Laere B; Crippa A; Discacciati A; Larsson B; Persson M; Johansson S; D'hondt S; Bergstrom R; Chellappa V; Mayrhofer M; Banijamali M; Kotsalaynen A; Schelstraete C; Vanwelkenhuyzen JP; Hjalm-Eriksson M; Pettersson L; Ullen A; Lumen N; Enblad G; Thellenberg Karlsson C; Janes E; Sandzen J; Schatteman P; Vigmostad M; Olsson M; Ghysel C; Sautois B; De Roock W; Van Bruwaene S; Anden M; Verbiene I; De Maeseneer D; Everaert E; Darras J; Aksnessether BY; Luyten D; Strijbos M; Mortezavi A; Oldenburg J; Ost P; Eklund M; Gronberg H; Lindberg J
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s991-s992Broer L; Oldenburg J; Mortezavi A; Lindberg J; Discacciati A; Karlsson CT; Ullen A; Janes E; Enblad G; Pettersson L; Vigmostad MN; Hjalm-Eriksson ME; Olsson M; Schatteman P; Ghysel C; De Laere B; Gronberg H; Ost P; Eklund M; Crippa A
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s978Kristiansen A; Sautois B; Crippa A; Mortezavi A; Discacciati A; Karlsson CT; Ullen A; Janes E; Enblad G; Oldenburg J; Sandzen J; Vigmostad MN; Hjalm-Eriksson ME; De Laere B; Strijbos MH; Ghysel C; Lindberg J; Eklund M; Ost P; Gronberg H
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s987Bultijnck R; Strijbos MH; Mortezavi A; Lindberg J; Discacciati A; Karlsson CT; Ullen A; Janes E; Enblad G; Oldenburg J; Sautois B; Hjalm-Eriksson ME; Haugnes HS; Schatteman P; Ghysel C; De Laere B; Eklund M; Gronberg H; Ost P; Crippa A
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s980Crippa A; Mortezavi A; Discacciati A; Karlsson CT; Strijbos MH; Janes E; Enblad G; Sautois B; Ullen A; Stenner-Liewen F; Hjalm-Eriksson ME; De Maeseneer DJ; Schatteman P; Ghysel C; Oldenburg J; Lindberg J; Ost P; Eklund M; Gronberg H; De Laere B
- Article: NATURE MEDICINE. 2024;30(9):2623-2630Salim M; Liu Y; Sorkhei M; Ntoula D; Foukakis T; Fredriksson I; Wang Y; Eklund M; Azizpour H; Smith K; Strand F
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2024;116(9):1459-1465Bjornebo L; Razdan S; Discacciati A; Palsdottir T; Aly M; Nordstrom T; Eklund M; Lundon D; Gronberg H; Tewari A; Wiklund P; Kyprianou N; Lantz A
- Article: BMC UROLOGY. 2024;24(1):168Jaderling F; Bergman M; Engel JC; Mortezavi A; Picker W; Haug ES; Eklund M; Nordstrom T
- Article: JOURNAL OF MAGNETIC RESONANCE IMAGING. 2024;60(2):458-468Fernandez-Quilez A; Nordstrom T; Jaederling F; Kjosavik SR; Eklund M
- Article: NEJM EVID. 2024;3(8):EVIDoa2400056Pihl E; Laszlo S; Rosenlund A-M; Kristoffersen MH; Schilcher J; Hedbeck CJ; Skorpil M; Micoli C; Eklund M; Skoeldenberg O; Frihagen F; Jonsson KB
- Article: LANCET ONCOLOGY. 2024;25(7):827-828Eklund M
- Article: VIRCHOWS ARCHIV. 2024;484(6):995-1003Egevad L; Micoli C; Delahunt B; Samaratunga H; Orrason AW; Garmo H; Stattin P; Eklund M
- Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e1213Falagario UG; Pellegrino F; Abbadi A; Björnebo L; Valdman A; Carrieri GG; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordström T; Grönberg H; Wiklund P; Lantz A
- Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e623Pellegrino F; Falagario UG; Abbadi A; Björnebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
- Article: EUROPEAN UROLOGY ONCOLOGY. 2024;7(2):213-221Egevad L; Micoli C; Samaratunga H; Delahunt B; Garmo H; Stattin P; Eklund M
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2024;62:61-67Arvendell M; Bjornebo L; Eklund M; Falagario UG; Engel JC; Akre O; Gronberg H; Nordstrom T; Lantz A
- Article: JAMA NETWORK OPEN. 2024;7(4):e247131Bjornebo L; Discacciati A; Falagario U; Vigneswaran HT; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Lantz A
- Journal article: EUROPEAN UROLOGY. 2024;85:s1692-s1693Vigneswaran HT; Eklund M; Discacciati A; Nordstrom T; Hubbard RA; Perlis N; Abern M; Moreira D; Eggener S; Yonover P; Chow A; Watts K; Liss M; Thoreson G; Abreu AL; Sonn GA; Palsdottir T; Plym A; Wiklund F; Gronberg H; Murphy AB
- Journal article: EUROPEAN UROLOGY. 2024;85:s1598Abbadi A; Eklund M; Lantz A; Discacciati A; Engel CJ; Bjornebo L; Falagario UG; Gronberg H; Nordstrom T
- Journal article: EUROPEAN UROLOGY. 2024;85:s1611Discacciati A; Abbadi A; Chandra J; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Gronberg H; Eklund M; Nordstrom T
- Journal article: EUROPEAN UROLOGY. 2024;85:s1674-s1675Vigneswaran HT; Palsdottir T; Gronberg H; Nordstrom T; Egevad L; Eklund M
- Journal article: EUROPEAN UROLOGY. 2024;85:s348Arvendell M; Bjornebo L; Eklund M; Falagario GU; Akre O; Gronberg H; Nordstrom T; Lantz A
- Journal article: EUROPEAN UROLOGY. 2024;85:s1402-s1403Falagario UG; Pellegrino F; Abbadi A; Bjornebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordstrom T; Gronberg H; Wiklund P; Lantz A
- Journal article: EUROPEAN UROLOGY. 2024;85:s1534-s1535Pellegrino F; Falagario UG; Abbadi A; Bjornebo L; Valdman A; Carrieri G; Briganti A; Montorsi F; Akre O; Aly M; Eklund M; Nordstrom T; Gronberg H; Lantz A; Wiklund P
- Article: JAMA NETWORK OPEN. 2024;7(2):e2354577Nordstrom T; Annerstedt M; Glaessgen A; Carlsson S; Clements M; Abbadi A; Groenberg H; Jaderling F; Eklund M; Discacciati A
- Article: PUBLIC HEALTH GENOMICS. 2024;27(1):177-196Riddle L; James JE; Naeim A; Madlensky L; Brain S; Derosa D; Eklund M; Fiscalini AS; Heditsian D; Koenig B; Ross K; Sabacan LP; Tong B; Wenger N; Joseph G
- Article: JOURNAL OF CLINICAL PATHOLOGY. 2023;77(1):22-26Flach RN; Egevad L; Eklund M; van der Kwast TH; Delahunt B; Samaratunga H; Suelmann BBM; Willemse P-PM; Meijer RP; van Diest PJ
- Article: NATURE GENETICS. 2023;55(12):2065-2074Wang A; Shen J; Rodriguez AA; Saunders EJ; Chen F; Janivara R; Darst BF; Sheng X; Xu Y; Chou AJ; Benlloch S; Dadaev T; Brook MN; Plym A; Sahimi A; Hoffman TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Laisk T; Figueredo J; Muir K; Ito S; Liu X; Uchio Y; Kubo M; Kamatani Y; Lophatananon A; Wan P; Andrews C; Lori A; Choudhury PP; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Rentsch CT; Cho K; Mcmahon BH; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder A; Stroomberg HV; Batra J; Chambers S; Horvath L; Clements JA; Tilly W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein S; Cook MB; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Butler EN; Mohler JL; Taylor JA; Kogevinas M; Dierssen-Sotos T; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Pilie P; Yu Y; Bohlender RJ; Gu J; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Brenner H; Chen X; Holleczek B; Schoettker B; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas CM; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Abraham A; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen J; Petrovics G; Casey G; Wang Y; Tettey Y; Lachance J; Tang W; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Yamoah K; Govindasami K; Chokkalingam AP; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Shittu O; Amodu O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Diop H; Gundell SM; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Kachuri L; Varma R; McKean-Cowdin R; Torres M; Preuss MH; Loos RJF; Zawistowski M; Zollner S; Lu Z; Van Den Eeden SK; Easton DF; Ambs S; Edwards TL; Magi R; Rebbeck TR; Fritsche L; Chanock SJ; Berndt SI; Wiklund F; Nakagawa H; Witte JS; Gaziano JM; Justice AC; Mancuso N; Terao C; Eeles RA; Kote-Jarai Z; Madduri RK; Conti DV; Haiman CA
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;57:s104-s105Möller A; Nordström T; Eklund M; Akre O; Egevad L; Aly M
- Article: JOURNAL OF HAND SURGERY GLOBAL ONLINE. 2023;5(6):733-739Harryson M; Eklund M; Arner M; Wilbrand S
- Article: BRITISH JOURNAL OF RADIOLOGY. 2023;96(1151):20230210Salim M; Dembrower K; Eklund M; Smith K; Strand F
- Journal article: ANNALS OF ONCOLOGY. 2023;34:s1327Gronberg H; Lindberg J; De laere B; Crippa A; Discacciati A; Karlsson CT; Ullen A; Janes E; Mortezavi A; Ost P; Enblad G; Oldenburg J; Sandzen J; Pettersson L; Vigmostad MN; Hjalm-Eriksson ME; Olsson M; Schatteman P; Ghysel C; Eklund M
- Article: LANCET DIGITAL HEALTH. 2023;5(10):e703-e711Dembrower K; Crippa A; Colon E; Eklund M
- Article: JAMA NETWORK OPEN. 2023;6(9):e2332900Falagario UG; Abbadi A; Remmers S; Bjornebo L; Bogdanovic D; Martini A; Valdman A; Carrieri G; Menon M; Akre O; Eklund M; Nordstrom T; Gronberg H; Lantz A; Wiklund P
- Article: BRITISH JOURNAL OF CANCER. 2023;129(1):61-71Hammarstroem M; Gabrielson M; Crippa A; Discacciati A; Eklund M; Lundholm C; Baecklund M; Wengstroem Y; Borgquist S; Bergqvist J; Eriksson M; Tapia J; Czene K; Hall P
- Article: LANCET DIGITAL HEALTH. 2023;5(7):e435-e445Kwong JCC; Khondker A; Meng E; Taylor N; Kuk C; Perlis N; Kulkarni GS; Hamilton RJ; Fleshner NE; Finelli A; van der Kwast TH; Ali A; Jamal M; Papanikolaou F; Short T; Srigley JR; Colinet V; Peltier A; Diamand R; Lefebvre Y; Mandoorah Q; Sanchez-Salas R; Macek P; Cathelineau X; Eklund M; Johnson AEW; Feifer A; Zlotta AR
- Journal article: CRITICAL CARE EXPLORATIONS. 2023;5(6):e0930Yang P; Dickert NW; Haczku A; Spainhour C; Auld SC
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_SUPPL):e18917Badel K; Staib J; Tice J; Kim M-O; Eklund M; Byfield SD; Catlett K; Wilson L; Maffey L; Soonavala R; Stover-Fiscalini A; Esserman L
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;51:89-94Lantz A; Nordlund P; Falagario U; Joderling F; Ozbek O; Clements M; Discacciati A; Gronberg H; Eklund M; Stricker P; Emberton M; Aly M; Nordstrom T
- Article: HISTOPATHOLOGY. 2023;82(6):837-845Egevad L; Delahunt B; Iczkowski KA; van der Kwast T; van Leenders GJLH; Leite KRM; Pan C-C; Samaratunga H; Tsuzuki T; Mulliqi N; Ji X; Olsson H; Valkonen M; Ruusuvuori P; Eklund M; Kartasalo K
- Article: EUROPEAN UROLOGY FOCUS. 2023;9(3):455-462Palsdottir T; Gronberg H; Hilmisson A; Eklund M; Nordstrom T; Vigneswaran HT
- Article: ECLINICALMEDICINE. 2023;58:101889I-SPY COVID Consortium
- Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e997Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Grönberg H; Nordström T; Eklund M
- Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e419Falagario U; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Wiklund P; Lantz A
- Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e214Falagario U; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Lantz A; Wiklund P
- Article: JOURNAL OF MEDICAL IMAGING. 2023;10(Suppl 2):S22405Dembrower K; Salim M; Eklund M; Lindholm P; Strand F
- Journal article: EUROPEAN UROLOGY. 2023;83:s1266-s1267Micoli C; Crippa A; Discacciati A; Vigneswaran H; Palsdottir T; Clements M; Aly M; Adolfsson J; Fredrik W; Wiklund P; James T; Lindberg J; Gronberg H; Egevad L; Nordstrom T; Eklund M
- Journal article: EUROPEAN UROLOGY. 2023;83:s1613-s1614Falagario UG; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Wiklund P; Lantz A
- Journal article: EUROPEAN UROLOGY. 2023;83:s379-s380Falagario UG; Bogdanovic D; Björnebo L; Abbadi A; Valdman A; Eklund M; Nordström T; Aly M; Grönberg H; Lantz A; Wiklund P
- Journal article: EUROPEAN UROLOGY. 2023;83:s1268Nordstrom T; Discacciati A; Annerstedt M; Mannsikka K; Glaessgen A; Carlsson S; Jaderling F; Gronberg H; Eklund M
- Journal article: EUROPEAN UROLOGY. 2023;83:s1293-s1294Palsdottir T; Gronberg H; Hilmisson A; Eklund M; Nordstrom T; Vigneswaran H
- Article: NATURE COMMUNICATIONS. 2022;13(1):7761Olsson H; Kartasalo K; Mulliqi N; Capuccini M; Ruusuvuori P; Samaratunga H; Delahunt B; Lindskog C; Janssen EAM; Blilie A; Egevad L; Spjuth O; Eklund M
- Article: JAMA ONCOLOGY. 2022;9(1):88-94Hao S; Discacciati A; Eklund M; Heintz E; Ostensson E; Elfstrom KM; Clements MS; Nordstrom T
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:46-51Ventimiglia E; Bill-Axelson A; Adolfsson J; Aly M; Eklund M; Westerberg M; Stattin P; Garmo H
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:69-75Andersson J; Palsdottir T; Lantz A; Aly M; Gronberg H; Egevad L; Eklund M; Nordstrom T
- Article: JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY. 2022;19(9):1021-1030Dontchos BN; Cavallo-Hom K; Lamb LR; Mercaldo SF; Eklund M; Dang P; Lehman CD
- Article: ISCIENCE. 2022;25(7):104663Liu B; Wang Y; Weitz P; Lindberg J; Hartman J; Wang W; Egevad L; Gronberg H; Eklund M; Rantalainen M
- Article: EUROPEAN UROLOGY. 2022;82(1):12-19Hao S; Heintz E; Ostensson E; Discacciati A; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Clements MS
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;41:1-7Engel JC; Palsdottir T; Ankerst D; Remmers S; Mortezavi A; Chellappa V; Egevad L; Gronberg H; Eklund M; Nordstrom T
- Article: JAMA ONCOLOGY. 2022;8(7):1019-1026Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
- Article: VIRCHOWS ARCHIV. 2022;481(1):73-82Kartasalo K; Strom P; Ruusuvuori P; Samaratunga H; Delahunt B; Tsuzuki T; Eklund M; Egevad L
- Article: BIOINFORMATICS. 2022;38(13):3462-3469Weitz P; Wang Y; Kartasalo K; Egevad L; Lindberg J; Gronberg H; Eklund M; Rantalainen M
- Article: BMJ OPEN. 2022;12(6):e060664Files DC; Matthay MA; Calfee CS; Aggarwal NR; Asare AL; Beitler JR; Berger PA; Burnham EL; Cimino G; Coleman MH; Crippa A; Discacciati A; Gandotra S; Gibbs KW; Henderson PT; Ittner CAG; Jauregui A; Khan KT; Koff JL; Lang J; LaRose M; Levitt J; Lu R; McKeehan JD; Meyer NJ; Russell DW; Thomas KW; Eklund M; Esserman LJ; Liu KD
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(3):169-175Bonde TM; Westerberg M; Aly M; Eklund M; Adolfsson J; Bill-Axelson A; Garmo H; Stattin P; Robinson D
- Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e991Björnebo L; Discacciati A; Eklund M; Grönberg H; Lantz A; Nordström T
- Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e41Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
- Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e255Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;38:32-39Walden M; Aldrimer M; Lagerlof JH; Eklund M; Gronberg H; Nordstrom T; Palsdottir T
- Article: BJUI COMPASS. 2022;3(2):173-183Khoshkar Y; Westerberg M; Adolfsson J; Bill-Axelson A; Olsson H; Eklund M; Akre O; Garmo H; Aly M
- Journal article: CANCER RESEARCH. 2022;82(4_Supplement):p5-19-04-p5-19-04Lewis T; Flores S; Sabacan L; Choy P; Thannickal H; Shieh Y; Tice J; Ziv E; Madlensky L; Eklund M; Yau C; Blanco A; Tong B; Goodman D; Anderson N; Harvey H; Fors S; Park HL; Raouf S; Stewart S; Wernisch J; Koenig B; Kaplan C; Hiatt R; Wenger N; Lee V; Heditsian D; Brain S; Moorehead D; Parker BA; Borowsky A; Anton-Culver H; Naeim A; Kaster A; van ‘t Veer L; LaCroix AZ; Olopade OI; Sheth D; Garcia A; Lancaster R; Plaza M; Fiscalini AS; Esserman L
- Journal article: CANCER RESEARCH. 2022;82(4_Supplement):p5-19-01-p5-19-01Choy P; Lewis T; Flores S; Sabacan L; Thannickal H; Goodman S; Shieh Y; Madlensky L; Tice JA; Ziv E; Eklund M; Blanco A; Tong B; Goodman D; Anderson N; Harvey H; Fors S; Park HL; Petruse A; Stewart S; Raouf S; Wernisch J; Koenig B; Kaplan C; Hiatt R; Wenger N; Lee V; Heditsian D; Brain S; Moorehead D; Parker BA; Borowsky A; Anton-Culver H; Naeim A; Kaster A; van 't Veer L; LaCroix AZ; Olopade OI; Sheth D; Garcia A; Lancaster R; James J; Joseph G; Study W; Fiscallini AS; Esserman L
- Journal article: EUROPEAN UROLOGY. 2022;81:s913Kartasalo K; Bulten W; Chen P-HC; Ström P; Pinckaers H; Nagpal K; Ruusuvuori P; Litjens G; Eklund M; Consortium PC
- Journal article: EUROPEAN UROLOGY. 2022;81:s915-s916Mulliqi N; Kartasalo K; Ji X; Szolnoky K; Olsson H; Blilie A; Braun M; Gambacorta M; Hotakainen K; Janssen EAM; Kjosavik SR; Łowicki R; Pedersen BG; Sørensen KD; Ulhøi BP; Ruusuvuori P; Egevad L; Eklund M
- Journal article: EUROPEAN UROLOGY. 2022;81:s561-s562Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
- Journal article: EUROPEAN UROLOGY. 2022;81:s554-s555Björnebo L; Discacciati A; Eklund M; Grönberg H; Lantz A; Nordström T
- Journal article: EUROPEAN UROLOGY. 2022;81:s792-s793Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
- Article: BREAST CANCER RESEARCH AND TREATMENT. 2022;191(3):623-629Dreher N; Matthys M; Hadeler E; Shieh Y; Acerbi I; McAuley FM; Melisko M; Eklund M; Tice JA; Esserman LJ; Van't Veer LJ
- Article: LAKARTIDNINGEN. 2022;119:21207Nordström T; Eklund M
- Article: BIOINFORMATICS. 2021;37(21):3995-3997Mulliqi N; Kartasalo K; Olsson H; Ji X; Egevad L; Eklund M; Ruusuvuori P
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;33:s216-s217Engel JC; Palsdottir T; Ankerst D; Remmers S; Mortezavi A; Chellappa V; Egevad L; Grönberg H; Eklund M; Nordström T
- Journal article: INVESTIGATIVE UROLOGY. 2021;206(Supplement 3):e565-e566Vigneswaran H; Mittelstaedt L; Crippa A; Eklund M; Vidal A; Freedland S; Abern M
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):299-306Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Eklund M; Nordstrom T; Eloranta S; Schain F; Dearden L; Liwing J; Mehra M; Nair S; Pettersson A; Akre O; Aly M
- Journal article: EUROPEAN UROLOGY. 2021;79:s1429Nordström T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
- Journal article: EUROPEAN UROLOGY. 2021;79:s1430Eklund M; Jäderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Grönberg H; Nordström T
- Article: WORLD JOURNAL OF UROLOGY. 2021;39(6):1797-1804Bjornebo L; Olsson H; Nordstrom T; Jaderling F; Gronberg H; Eklund M; Lantz A
- Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2021;24(2):457-464Vigneswaran HT; Palsdottir T; Olsson H; Haug ES; Picker W; Loffeler S; Gronberg H; Eklund M; Nordstrom T
- Article: VIRCHOWS ARCHIV. 2021;478(6):1109-1116Egevad L; Delahunt B; Samaratunga H; Tsuzuki T; Olsson H; Strom P; Lindskog C; Hakkinen T; Kartasalo K; Eklund M; Ruusuvuori P
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2021;113(5):632-640Olsson H; Nordstrom T; Jaderling F; Egevad L; Vigneswaran HT; Annerstedt M; Gronberg H; Eklund M; Lantz A
- Article: EUROPEAN UROLOGY FOCUS. 2021;7(3):546-553Mortezavi A; Palsdottir T; Eklund M; Chellappa V; Murugan SK; Saba K; Ankerst DP; Haug ES; Nordstrom T; Tilki D
- Article: CANCERS. 2021;13(7):1588De Laere B; Crippa A; Mortezavi A; Ghysel C; Rajan P; Eklund M; Wyatt A; Dirix L; Ost P; Gronberg H; Lindberg J
- Article: MODERN PATHOLOGY. 2021;34(3):660-671Bulten W; Balkenhol M; Belinga J-JA; Brilhante A; Cakir A; Egevad L; Eklund M; Farre X; Geronatsiou K; Molinie V; Pereira G; Roy P; Saile G; Salles P; Schaafsma E; Tschui J; Vos A-M; van Boven H; Vink R; van der Laak J; Hulsbergen-van der Kaa C; Litjens G
- Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2021;24(1):120-127Vigneswaran HT; Discacciati A; Gann PH; Gronberg H; Eklund M; Abern MR
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:43-51Koitsalu M; Eklund M; Adolfsson J; Sprangers MAG; Gronberg H; Brandberg Y
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:11-16Nordstrom T; Engel JC; Bergman M; Egevad L; Aly M; Eklund M; Palsdottir T; Gronberg H
- Article: NATURE GENETICS. 2021;53(1):65-75Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Al Olama AA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Burnet N; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Fontham ETH; Mohler J; Taylor JA; Kogevinas M; Llorca J; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Weaver B; Brenner H; Cuk K; Holleczek B; Saum K-U; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Casey G; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Varma R; McKean-Cowdin R; Torres M; Mancuso N; Berndt SI; Van den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Nakagawa H; Witte JS; Eeles RA; Kote-Jarai Z; Haiman CA
- Article: VIRCHOWS ARCHIV. 2020;477(6):777-786Egevad L; Swanberg D; Delahunt B; Strom P; Kartasalo K; Olsson H; Berney DM; Bostwick DG; Evans AJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M; Eklund M
- Article: JOURNAL OF CLINICAL PATHOLOGY. 2020;73(10):630-635Strom P; Nordstrom T; Delahunt B; Samaratunga H; Gronberg H; Egevad L; Eklund M
- Article: EUROPEAN UROLOGY ONCOLOGY. 2020;3(5):640-647Olsson H; Nordstrom T; Clements M; Gronberg H; Lantz AW; Eklund M
- Article: RADIOLOGY. 2020;297(1):33-39Salim M; Dembrower K; Eklund M; Lindholm P; Strand F
- Article: PLOS ONE. 2020;15(9):e0238217Morgantini LA; Naha U; Wang H; Francavilla S; Acar O; Flores JM; Crivellaro S; Moreira D; Abern M; Eklund M; Vigneswaran HT; Weine SM
- Article: LANCET DIGITAL HEALTH. 2020;2(9):e468-e474Dembrower K; Wahlin E; Liu Y; Salim M; Smith K; Lindholm P; Eklund M; Strand F
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e519-e520Vigneswaran HT; Olsson H; Haug ES; Grönberg H; Eklund M; Nordström T
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e260-e261Vigneswaran HT; Discacciati A; Gann P; Grönberg H; Eklund M; Abern MR
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e182Bergman MCA; Mortezawi A; Picker W; Aly M; Jäderling F; Haug E; Eklund M; Nordström T
- Article: TRIALS. 2020;21(1):579Crippa A; De Laere B; Discacciati A; Larsson B; Connor JT; Gabriel EE; Thellenberg C; Janes E; Enblad G; Ullen A; Hjalm-Eriksson M; Oldenburg J; Ost P; Lindberg J; Eklund M; Gronberg H
- Article: BMC HEALTH SERVICES RESEARCH. 2020;20(1):448Hao S; Ostensson E; Eklund M; Gronberg H; Nordstrom T; Heintz E; Clements M
- Article: JNCI CANCER SPECTRUM. 2020;4(2):pkaa016Eklund M; Broglio K; Yau C; Connor JT; Fiscalini AS; Esserman LJ
- Journal article: INVESTIGATIVE UROLOGY. 2020;203:e1100Vigneswaran* H; Olsson H; Haug ES; Grönberg H; Eklund M; Nordström T
- Journal article: INVESTIGATIVE UROLOGY. 2020;203:e1148Vigneswaran* HT; Discacciati A; Gann P; Grönberg H; Eklund M; Abern MR
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps378Nordström T; Discacciati A; Jäderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps379Lantz A; Olsson H; Nordström T; Jäderling F; Egevad L; Annerstedt M; Gronberg H; Eklund M
- Article: RADIOLOGY. 2020;294(2):265-272Dembrower K; Liu Y; Azizpour H; Eklund M; Smith K; Lindholm P; Strand F
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(1):1-6Engel JC; Palsdottir T; Aly M; Egevad L; Gronberg H; Eklund M; Nordstrom T
- Article: JAMA NETWORK OPEN. 2019;2(11):e1914689Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy ResultsBeckmann K; Crawley D; Nordstrom T; Aly M; Olsson H; Lantz A; Abd Jalal NB; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
- Journal article: ANNALS OF ONCOLOGY. 2019;30:v354Lindberg J; De Laere B; Crippa A; Eklund M; Grönberg H
- Journal article: ANNALS OF ONCOLOGY. 2019;30:v30-v31De Laere B; Crippa A; Ghysel C; Ost P; Rajan P; Eklund M; Dirix L; Grönberg H; Lindberg J
- Article: BMJ OPEN. 2019;9(9):e031607Pihl E; Kristoffersen MH; Rosenlund A-M; Laszlo S; Berglof M; Ribom E; Eriksson K; Frihagen F; Mattila VM; Schilcher J; Eklund M; Snellman G; Skorpil M; Skoldenberg O; Hedbeck CJ; Jonsson K
- Article: EUROPEAN UROLOGY ONCOLOGY. 2019;2(5):490-496Palsdottir T; Nordstrom T; Aly M; Jaderling F; Clements M; Gronberg H; Eklund M
- Article: BMC UROLOGY. 2019;19(1):73Beckmann K; Kinsella N; Olsson H; Lantz AW; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
- Article: JOURNAL OF HAND THERAPY. 2019;32(3):328-333Edsfeldt S; Eklund M; Wiig M
- Article: BMJ OPEN. 2019;9(6):e027816Nordstrom T; Jaderling F; Carlsson S; Aly M; Gronberg H; Eklund M
- Article: PLOS ONE. 2019;14(6):e0218280Palsdottir T; Nordstrom T; Aly M; Lindberg J; Clements M; Egevad L; Gronberg H; Eklund M
- Journal article: INVESTIGATIVE UROLOGY. 2019;201(Supplement 4)Beckmann* K; Kinsella N; Olsen H; Wallerstedt-Lantz A; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
- Article: BMJ OPEN. 2019;9(3):e027958Palsdottir T; Nordstrom T; Karlsson A; Gronberg H; Clements M; Eklund M
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2019;18(1):e1532Jalal NBA; Garmo H; Nordstrom T; Aly M; Eklund M; Aldofsson J; Van Hemelrijck M; Beckmann K
- Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2019;22(1):137-142Moller A; Olsson H; Gronberg H; Eklund M; Aly M; Nordstrom T
- Article: INTERNATIONAL JOURNAL OF CANCER. 2019;144(5):1195-1204Li J; Wen WX; Eklund M; Kvist A; Eriksson M; Christensen HN; Torstensson A; Bajalica-Lagercrantz S; Dunning AM; Decker B; Allen J; Luccarini C; Pooley K; Simard J; Dorling L; Easton DF; Teo S-H; Hall P; Borg A; Gronberg H; Czene K
- Article: PLOS ONE. 2019;14(2):e0211918Karlsson A; Jauhiainen A; Gulati R; Eklund M; Gronberg H; Etzioni R; Clements M
- Article: EUROPEAN UROLOGY. 2018;74(6):722-728Gronberg H; Eklund M; Picker W; Aly M; Jaderling F; Adolfsson J; Landquist M; Haug ES; Strom P; Carlsson S; Nordstrom T
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(14):e2898-e2899Engel JC; Aly M; Grönberg H; Eklund M; Nordström T
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2018;110(11):1216-1221Wallerstedt A; Strom P; Gronberg H; Nordstrom T; Eklund M
- Article: EUROPEAN UROLOGY FOCUS. 2018;4(5):707-710Eklund M; Nordstrom T; Aly M; Adolfsson J; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Presti JC; StLezin M; Clements M; Egevad L; Gronberg H
- Article: EUROPEAN UROLOGY. 2018;74(2):204-210Strom P; Nordstrom T; Aly M; Egevad L; Gronberg H; Eklund M
- Article: PLOS ONE. 2018;13(7):e0200409Koitsalu M; Eklund M; Adolfsson J; Sprangers MAG; Gronberg H; Brandberg Y
- Article: NATURE GENETICS. 2018;50(7):928-936Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Dominguez MG; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA
- Article: NATURE COMMUNICATIONS. 2018;9(1):2256Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Al Olama AA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weisher M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Slavov C; Mitev V; Parliament M; Singhal S; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Kierzek A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Kraft P; Freedman M; Wiklund F; Chanock S; Henderson BE; Easton DF; Haiman CA; Eeles RA; Conti DV; Kote-Jarai Z
- Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2018;21(1):57-63Nordstrom T; Akre O; Aly M; Gronberg H; Eklund M
- Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):385-387Nordstrom T; Gronberg H; Adolfsson J; Egevad L; Aly M; Eklund M
- Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(4):741-746Heijnsdijk EAM; Bangma CH; Borras JM; de Carvalho TM; Castells X; Eklund M; Espinas JA; Graefen M; Gronberg H; Lansdorp-Vogelaar I; van Leeuwen PJ; Nelen V; Recker F; Roobol MJ; Vandenbulcke P; de Koning HJ
- Journal article: CANCER RESEARCH. 2018;78(4_Supplement):pd2-14-pd2-14Naeim A; Sepucha K; Wenger N; Eklund M; Annette S; Madlensky L; van't Veer L; Parker B; Yau C; Cink T; Anton-Culver H; Borowsky A; Petruse A; Sarrafan S; Stover-Fiscalini A; LaCroix A; Adduci K; Laura E
- Journal article: CANCER RESEARCH. 2018;78(4_Supplement):p4-12-03-p4-12-03Wimmer K; Stover Fiscalini A; Eklund M; DiGiorgio K; Naeim A; Esserman L
- Journal article: CANCER RESEARCH. 2018;78(4_Supplement):p3-09-02-p3-09-02Shieh Y; Ziv E; Eklund M; Sabacan L; Firouzian R; Madlensky L; Anton-Culver H; Borowsky A; LaCroix A; Naeim A; Parker B; van't Veer L; Esserman L; Tice J
- Article: BREAST CANCER RESEARCH. 2018;20(1):14Bystrom S; Eklund M; Hong M-G; Fredolini C; Eriksson M; Czene K; Hall P; Schwenk JM; Gabrielson M
- Article: BMC MEDICAL RESEARCH METHODOLOGY. 2018;18(1):3Koitsalu M; Eklund M; Adolfsson J; Gronberg H; Brandberg Y
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2017;16(10):e2628-e2629Nordström; Picker W; Aly M; Jäderling F; Adolfsson J; Ström P; Haug ES; Eklund M; Carlsson S; Grönberg H
- Article: BMC UROLOGY. 2017;17(1):92Nordstrom T; Adolfsson J; Gronberg H; Eklund M
- Article: JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION. 2017;24(5):950-957Spjuth O; Karlsson A; Clements M; Humphreys K; Ivansson E; Dowling J; Eklund M; Jauhiainen A; Czene K; Gronberg H; Sparen P; Wiklund F; Cheddad A; Palsdottir P; Rantalainen M; Abrahamsson L; Laure E; Litton J-E; Palmgren J
- Article: WORLD JOURNAL OF UROLOGY. 2017;35(6):895-896Nordstrom T; Eklund M; Gronberg H
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2016;108(12):djw165Nordstrom T; Adolfsson J; Gronberg H; Eklund M
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):5050Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2016;15(3):e86Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2016;15(3):e97Nordström T; Adolfsson J; Grönberg H; Eklund M
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(3):251-258Holm J; Li J; Darabi H; Eklund M; Eriksson M; Humphreys K; Hall P; Czene K
- Article: ACTA ONCOLOGICA. 2016;55(1):45-51Koitsalu M; Sprangers MAG; Eklund M; Czene K; Hall P; Gronberg H; Brandberg Y
- Article: PROSTATE. 2015;75(13):1467-1474Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubinski J; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lim H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Gronberg H; Wiklund F
- Article: EUROPEAN UROLOGY. 2015;68(1):139-146Nordstrom T; Vickers A; Assel M; Lilja H; Gronberg H; Eklund M
- Article: ANNALS OF MATHEMATICS AND ARTIFICIAL INTELLIGENCE. 2015;74(1-2):117-132Eklund M; Norinder U; Boyer S; Carlsson L
- Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2015;71(2):279-284Norinder U; Carlsson L; Boyer S; Eklund M
- Article: JOURNAL OF CHEMICAL INFORMATION AND MODELING. 2015;55(1):19-25Moghadam BT; Alvarsson J; Holm M; Eklund M; Carlsson L; Spjuth O
- Article: JOURNAL OF CHEMICAL INFORMATION AND MODELING. 2014;54(11):3211-3217Alvarsson J; Eklund M; Andersson C; Carlsson L; Spjuth O; Wikberg JES
- Article: JOURNAL OF CHEMICAL INFORMATION AND MODELING. 2014;54(10):2647-2653Alvarsson J; Eklund M; Engkvist O; Spjuth O; Carlsson L; Wikberg JES; Noeske T
- Article: JOURNAL OF CHEMICAL INFORMATION AND MODELING. 2014;54(6):1596-1603Norinder U; Carlsson L; Boyer S; Eklund M
- Article: EUROPEAN UROLOGY. 2014;65(6):1184-1190Nordstrom T; Aly M; Eklund M; Egevad L; Gronberg H
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2014;13(1):e339Nordström T; Vickers AJ; Lilja HG; Grönberg H; Eklund M
- Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2014;13(1):e860Gronberg H; Eklund M; Clements M; Nordström T; Aly M; Egevad L; Wiklund F; Brandeberg Y; Wiklund P; Adolfsson J
- Article: JOURNAL OF CHEMICAL INFORMATION AND MODELING. 2014;54(3):837-843Eklund M; Norinder U; Boyer S; Carlsson L
- Article: ANNALS OF INTERNAL MEDICINE. 2014;160(3):145-153O'Donoghue C; Eklund M; Ozanne EM; Esserman LJ
- Journal article: CHEMINFORM. 2013;44(31):noSpjuth O; Carlsson L; Alvarsson J; Georgiev V; Willighagen E; Eklund M
- Article: JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN. 2013;27(3):203-219Wood DJ; Carlsson L; Eklund M; Norinder U; Stalring J
- Article: BIOINFORMATICS. 2013;29(2):286-289Bioclipse-R: integrating management and visualization of life science data with statistical analysisSpjuth O; Georgiev V; Carlsson L; Alvarsson J; Berg A; Willighagen E; Wikberg JES; Eklund M
- Journal article: CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2013;12(18):1980-1986Spjuth O; Alvarsson J; Willighagen E; Carlsson L; Georgiev V; Eklund M
- Article: JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION. 2012;82(4):515-527Eklund M; Zwanzig S
- Article: MOLECULAR INFORMATICS. 2012;31(2):173-179Eklund M; Norinder U; Boyer S; Carlsson L
- Article: JOURNAL OF CHEMICAL INFORMATION AND MODELING. 2011;51(8):1840-1847Spjuth O; Eklund M; Helgee EA; Boyer S; Carlsson L
- Article: EUROPEAN UROLOGY. 2011;60(1):21-28Aly M; Wiklund F; Xu J; Isaacs WB; Eklund M; D'Amato M; Adolfsson J; Gronberg H
- Article: BIOINFORMATICS. 2011;27(12):1719-1720Spjuth O; Eklund M; Lapins M; Junaid M; Wikberg JES
- Article: JOURNAL OF BIOMEDICAL SEMANTICS. 2011;240(Suppl 1):S6Willighagen EL; Wikberg JES
- Article: PLOS ONE. 2010;5(12):e14353Junaid M; Lapins M; Eklund M; Spjuth O; Wikberg JES
- Article: JOURNAL OF CHEMINFORMATICS. 2010;2(1):5Spjuth O; Willighagen EL; Guha R; Eklund M; Wikberg JES
- Article: MOLECULAR ECOLOGY. 2010;19(11):2229-2240Rogell B; Eklund M; Thörngren H; Laurila A; Höglund J
- Article: BMC BIOINFORMATICS. 2010;11:282Eklund M; Spjuth O; Wikberg JES
- Article: BMC BIOINFORMATICS. 2009;10:397Spjuth O; Alvarsson J; Berg A; Eklund M; Kuhn S; Masak C; Torrance G; Wagener J; Willighagen EL; Steinbeck C; Wikberg JES
- Article: JOURNAL OF EVOLUTIONARY BIOLOGY. 2009;22(11):2267-2277Rogell B; Hofman M; Eklund M; Laurila A; Höglund J
- Article: JOURNAL OF MICROBIOLOGICAL METHODS. 2008;75(2):219-224Lundén K; Eklund M; Finlay R; Stenlid J; Asiegbu FO
- Article: BMC BIOINFORMATICS. 2008;9:360Eklund M; Spjuth O; Wikberg JES
- Article: BMC BIOINFORMATICS. 2008;9:181Lapins M; Eklund M; Spjuth O; Prusis P; Wikberg JES
- Article: BMC BIOINFORMATICS. 2007;8:59Spjuth O; Helmus T; Willighagen EL; Kuhn S; Eklund M; Wagener J; Murray-Rust P; Steinbeck C; Wikberg JES
- Article: FEMS MICROBIOLOGY ECOLOGY. 2006;57(1):26-39Adomas A; Eklund M; Johansson M; Asiegbu FO
- Show more
All other publications
- Preprint: COLD SPRING HARBOR LABORATORY. 2025Ji X; Zelic R; Aspegren O; Mulliqi N; Fiorentino M; Giunchi F; Molinaro L; Boman SE; Szolnoky K; Liu LX; Pettersson A; Vincent PH; Eklund M; Akre O; Kartasalo K
- Review: PATHOLOGY INTERNATIONAL. 2025;75(5):213-220Egevad L; Camilloni A; Delahunt B; Samaratunga H; Eklund M; Kartasalo K
- Preprint: ARXIV. 2025Blilie A; Mulliqi N; Ji X; Szolnoky K; Boman SE; Titus M; Gonzalez GM; Asenjo J; Gambacorta M; Libretti P; Gudlaugsson E; Kjosavik SR; Egevad L; Janssen EAM; Eklund M; Kartasalo K
- Preprint: MEDRXIV. 2025Micoli C; Discacciati A; Eklund M
- Book chapter: CANCER PREVENTION, DETECTION, AND INTERVENTION: LECTURE NOTES IN COMPUTER SCIENCE. 2025;p. 73-82Sortland Rolfsnes E; Thangngat P; Eftestøl T; Nordström T; Jäderling F; Eklund M; Fernandez-Quilez A
- Preprint: ARXIV. 2024Micoli C; Crippa A; Connor JT; Consortium I-SC; Eklund M; Discacciati A
- Editorial comment: NATURE REVIEWS UROLOGY. 2024;:1-4Szolnoky K; Nordstrom T; Eklund M
- Corrigendum: NATURE MEDICINE. 2024;30(11):3381De Laere B; Crippa A; Discacciati A; Larsson B; Persson M; Johansson S; D'hondt S; Bergstrom R; Chellappa V; Mayrhofer M; Banijamali M; Kotsalaynen A; Schelstraete C; Vanwelkenhuyzen JP; Hjaelm-Eriksson M; Pettersson L; Ullen A; Lumen N; Enblad G; Karlsson CT; Jaenes E; Sandzen J; Schatteman P; Vigmostad MN; Olsson M; Ghysel C; Sautois B; De Roock W; Van Bruwaene S; Anden M; Verbiene I; De Maeseneer D; Everaert E; Darras J; Aksnessether BY; Luyten D; Strijbos M; Mortezavi A; Oldenburg J; Ost P; Eklund M; Gronberg H; Lindberg J
- Preprint: MEDRXIV. 2024Mulliqi N; Blilie A; Ji X; Szolnoky K; Olsson H; Titus M; Gonzalez GM; Boman SE; Valkonen M; Gudlaugsson E; Kjosavik SR; Asenjo J; Gambacorta M; Libretti P; Braun M; Kordek R; Łowicki R; Hotakainen K; Väre P; Pedersen BG; Sørensen KD; Ulhøi BP; Rantalainen M; Ruusuvuori P; Delahunt B; Samaratunga H; Tsuzuki T; Janssen EAM; Egevad L; Kartasalo K; Eklund M
- Preprint: MEDRXIV. 2024Mayrhofer M; Bergström R; Chellappa V; Kotsalaynen A; Murugan S; Crippa A; De Laere B; Urtishak K; Sorensen KD; Garg K; Singh U; Eklund M; Grönberg H; Lindberg J
- Conference publication: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024;209:a1120Mabrey L; Esserman L; Liu K; Files D; Eklund M; Calfee CS; Burnham EL; Martin TR; Wurfel MM
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(4_SUPPL):262Vigneswaran HT; Eklund M; Discacciati A; Nordstrom T; Hubbard RA; Perlis N; Abern M; Moreira D; Yonover PM; Chow A; Watts K; Liss MA; Thoreson GR; Abreu AL; Sonn GA; Palsdottir T; Wiklund F; Gronberg H; Murphy AB
- Preprint: ARXIV. 2023Rolfsnes ES; Thangngat P; Eftestøl T; Nordström T; Jäderling F; Eklund M; Fernandez-Quilez A
- Preprint: MEDRXIV. 2023Fernandez-Quilez A; Nordström T; Eftestøl T; Alvestad AB; Jäderling F; Kjosavik SR; Eklund M
- Preprint: ARXIV. 2023Leveraging multi-view data without annotations for prostate MRI segmentation: A contrastive approachLindeijer TN; Ytredal TM; Eftestøl T; Nordström T; Jäderling F; Eklund M; Fernandez-Quilez A
- Preprint: ARXIV. 2023Fernandez-Quilez A; Nordström T; Jäderling F; Kjosavik SR; Eklund M
- Preprint: ARXIV. 2023Ji X; Salmon R; Mulliqi N; Khan U; Wang Y; Blilie A; Olsson H; Pedersen BG; Sørensen KD; Ulhøi BP; Kjosavik SR; Janssen EA; Rantalainen M; Egevad L; Ruusuvuori P; Eklund M; Kartasalo K
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)Badal K; Staib J; Tice J; Kim M-O; Eklund M; Byfield SD; Catlett K; Wilson L; Maffey L; Soonavala R; Stover-Fiscalini A; Esserman L
- Conference publication: JOURNAL OF UROLOGY. 2023;209:E997-E998Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Gronberg H; Nordstrom T; Eklund M
- Conference publication: JOURNAL OF UROLOGY. 2023;209:E214-E215Falagario U; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Lantz A; Wiklund P
- Conference publication: JOURNAL OF UROLOGY. 2023;209:E419Falagario U; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Wiklund P; Lantz A
- Conference publication: EUROPEAN UROLOGY. 2023;83:S379-S380Falagario UG; Bogdanovic D; Bjornebo L; Abbadi A; Valdman A; Eklund M; Nordstrom T; Aly M; Gronberg H; Lantz A; Wiklund P
- Conference publication: EUROPEAN UROLOGY. 2023;83:S685-S686Kwong J; Khondker A; Meng E; Taylor N; Perlis N; Kulkarni GS; Hamilton RJ; Fleshner NE; Finelli A; Van Der Kwast TH; Srigley JR; Jamal M; Colinet V; Peltier A; Diamand R; Lefebvre Y; Mandoorah Q; Sanchez-Salas R; Macek P; Cathelineau X; Eklund M; Johnson AEW; Feifer AH; Zlotta AR
- Editorial comment: EUROPEAN UROLOGY FOCUS. 2022;8(6):1617-1621De laere B; Crippa A; Discacciati A; Larsson B; Oldenburg J; Mortezavi A; Ost P; Eklund M; Lindberg J; Gronberg H
- Letter: JAMA ONCOLOGY. 2022;8(12):1852Bjornebo L; Eklund M; Lantz A
- Corrigendum: EUROPEAN UROLOGY. 2022;82(1):e21Hao S; Heintz E; Ostensson E; Discacciati A; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Clements MS
- Preprint: MEDRXIV. 2022Files DC; Matthay MA; Calfee CS; Aggarwal N; Asare AL; Beitler JR; Berger PA; Burnham EL; Cimino G; Coleman MH; Crippa A; Discacciati A; Gandotra S; Gibbs KW; Henderson PT; Ittner CAG; Jauregui A; Khan KT; Koff JL; Lang J; LaRose M; Levitt J; Lu R; McKeehan JD; Meyer NJ; Russell DW; Thomas KW; Eklund M; Esserman LJ; Liu KD
- Conference publication: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2022;205:a5284Calfee CS; Eklund M; Albertson TE; Auld S; Beitler JR; Berger PA; Burnham EL; Cobb NK; Crippa A; Daniel BM; Discacciati A; Files DC; Friedman EB; Gandotra S; Gong MN; Khan KT; Koff JL; Kumar SI; Lang JE; Lu R; Martin TR; Matthay MA; Meyer NJ; Moskowitz A; Obermiller TF; Robinson PA; Russell D; Thomas KW; Wong S; Wurfel MM; Wunderink RG; Yen YF; Youssef FA; Esserman LJ; Liu KD
- Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E991-E992Bjornebo L; Discacciati A; Eklund M; Gronberg H; Lantz A; Nordstrom T
- Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E41Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
- Review: EUROPEAN UROLOGY FOCUS. 2022;8(2):409-417Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
- Review: PROSTATE CANCER AND PROSTATIC DISEASES. 2022;25(2):165-173Vigneswaran HT; Mittelstaedt L; Crippa A; Eklund M; Vidal A; Freedland SJ; Abern MR
- Conference publication: EUROPEAN UROLOGY. 2022;81:S915-S916Mulliqi N; Kartasalo K; Ji X; Szolnoky K; Olsson H; Blilie A; Braun M; Gambacorta M; Hotakainen K; Janssen EAM; Kjosavik SR; Lowicki R; Pedersen BG; Sorensen KD; Ulhoi BP; Ruusuvuori P; Egevad L; Eklund M
- Conference publication: EUROPEAN UROLOGY. 2022;81:S561-S562Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
- Conference publication: EUROPEAN UROLOGY. 2022;81:S554-S555Bjornebo L; Discacciati A; Eklund M; Gronberg H; Lantz A; Nordstrom T
- Conference publication: EUROPEAN UROLOGY. 2022;81:S792-S793Ventimiglia E; Bill-Axelson A; Aly M; Eklund M; Stattin P; Garmo H
- Conference publication: EUROPEAN UROLOGY. 2022;81:S913Kartasalo K; Bulten W; Chen P-HC; Strom P; Pinckaers H; Nagpal K; Ruusuvuori P; Litjens G; Eklund M
- Editorial comment: JOURNAL OF UROLOGY. 2022;207(1):231Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
- Letter: NATURE MEDICINE. 2022;28(1):9-11Calfee CS; Liu KD; Asare AL; Beitler JR; Berger PAIII; Coleman MH; Crippa A; Discacciati A; Eklund M; Files DC; Gandotra S; Gibbs KW; Henderson P; Levitt JE; Lu R; Matthay MA; Meyer NJ; Russell DW; Thomas KW; Esserman LJ; Mittel AM; Dzierba AL; Madahar P; Serra AL; Rosen A; Garcia I; Muir J; Schicchi J; Darmanian A; Wahab R; Gosek K; Auld SC; Adelman MW; Nugent KL; Harris GH; Creel-Bulos C; Yang P; Detelich JF; Spainhour C; Cobb NK; Sonti R; Orr LA; Robinson PA; Sarafian F; Martinez E; Jones P; Nguyen J; Obermiller TF; Weiler-Lisowski B; Kufa L; Saba PL; Wyatt J; Youssef FA; Tanios M; Blevins D; Macias LR; Suarez AE; Reyes MB; Jung M; Melendrez M; Rosario-Remigio L; Su H; Friedman EB; Angelucci CM; Chaparro-Rojas F; Sternlieb MP; Sutter JB; Whealon S; Nair R; Lopez B; Amosu O; Tzehaie H; Wunderink RG; Patel C; Simonson A; Dodin J; Oliver T; Lupu RA; Meyers M; Albertson TE; Haczku A; Hardy E; Morrissey BM; Juarez MM; Pearson SJ; Lee RA; Amin AN; Jauregui A; Fields S; Ng D; Daniel BM; Yee K; Jones C; Burnham EL; McKeehan JD; Ittner CAG; Reilly JP; Mangalmurti NS; Rodrigues LG; Weisman AR; Khan KT; Wong SF; Yen AF; Peterfreund G; Kumar SI; Marshall PS; Huerta LE; Lindgren B; Lee JS; Barker AD; Lang JE; LaRose M; Landreth L; Parks L; Barot HV; Koff JL; Kazianis J; Boerger LL
- Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2021;385(22):2110-2111Eklund M; Discacciati A; Nordström T
- Editorial comment: BREAST CANCER RESEARCH AND TREATMENT. 2021;189(3):593-598Esserman L; Eklund M; Van't Veer L; Shieh Y; Tice J; Ziv E; Blanco A; Kaplan C; Hiatt R; Fiscalini AS; Yau C; Scheuner M; Naeim A; Wenger N; Lee V; Heditsian D; Brain S; Parker BA; LaCroix AZ; Madlensky L; Hogarth M; Borowsky A; Anton-Culver H; Kaster A; Olopade OI; Sheth D; Garcia A; Lancaster R; Plaza M
- Editorial comment: PATHOLOGY. 2021;53(5):565-567Egevad L; Delahunt B; Samaratunga H; Tsuzuki T; Yamamoto Y; Yaxley J; Ruusuvuori P; Kartasalo K; Eklund M
- Review: EUROPEAN UROLOGY FOCUS. 2021;7(4):687-691Kartasalo K; Bulten W; Delahunt B; Chen P-HC; Pinckaers H; Olsson H; Ji X; Mulliqi N; Samaratunga H; Tsuzuki T; Lindberg J; Rantalainen M; Wahlby C; Litjens G; Ruusuvuori P; Egevad L; Eklund M
- Preprint: ARXIV. 2021Liu B; Wang Y; Weitz P; Lindberg J; Hartman J; Egevad L; Grönberg H; Eklund M; Rantalainen M
- Conference publication: EUROPEAN UROLOGY. 2021;79:S1429Nordstrom T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
- Conference publication: EUROPEAN UROLOGY. 2021;79:S1430Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
- Preprint: ARXIV. 2021Weitz P; Wang Y; Kartasalo K; Egevad L; Lindberg J; Grönberg H; Eklund M; Rantalainen M
- Preprint: MEDRXIV. 2021Hao S; Heintz E; Östensson E; Discacciati A; Jäderling F; Grönberg H; Eklund M; Nordström T; Clements M
- Corrigendum: NATURE GENETICS. 2021;53(3):413Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Al Olama AA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokolorczyk D; Lubinski J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Roder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordstrom T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin H-Y; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IMJ; Hamilton RJ; Fleshner NE; Finelli A; Parent M-E; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Hakansson N; Andriole GL; Hoover RN; Machiela MJ; Sorensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu Y-J; Zhang H-W; Feng N; Mao X; Wu Y; Zhao S-C; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Burnet N; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw K-T; Ingles SA; Stern MC; Vega A; Gomez-Caamano A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandao A; Watya S; Lubwama A; Bensen JT; Fontham ETH; Mohler J; Taylor JA; Kogevinas M; Llorca J; Castano-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Weaver B; Brenner H; Cuk K; Holleczek B; Saum K-U; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo S-H; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Casey G; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Varma R; McKean-Cowdin R; Torres M; Mancuso N; Berndt SI; Van den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Nakagawa H; Witte JS; Eeles RA; Kote-Jarai Z; Haiman CA
- Conference publication: CANCER RESEARCH. 2021;81(4)Acerbi I; Fiscalini AS; Che M; Shieh Y; Madlensky L; Tice J; Ziv E; Eklund M; Blanco A; Tong B; Goodman D; Nassereddine L; Anderson N; Harvey H; Fors S; Park HL; Petruse A; Stewart S; Wernisch J; Risty L; Hurley I; Koenig B; Kaplan C; Hiatt R; Wenger N; Lee V; Heditsian D; Brain S; Sabacan L; Wang T; Parker BA; Borowsky A; Anton-Culver H; Naeim A; Kaster A; Talley M; van 't Veer L; LaCroix AZ; Olopade OI; Sheth D; Garcia A; Lancaster R; Esserman L
- Preprint: SSRN ELECTRONIC JOURNAL. 2021Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
- Letter: BJU INTERNATIONAL. 2020;125(6):763-764Mortezavi A; Eklund M; Bergman M; Kjosavik SR; Discacciati A; Nordstrom T
- Preprint: MEDRXIV. 2020;MEDRXIVMorgantini LA; Naha U; Wang H; Francavilla S; Acar Ö; Flores JM; Crivellaro S; Moreira D; Abern M; Eklund M; Vigneswaran HT; Weine SM
- Preprint: RESEARCH SQUARE. 2020Crippa A; De Laere B; Discacciati A; Larsson B; Connor JT; Gabriel EE; Thellenberg C; Jänes E; Enblad G; Ullen A; Hjälm-Eriksson M; Oldenburg J; Ost P; Lindberg J; Eklund M; Grönberg H
- Editorial comment: HISTOPATHOLOGY. 2020;76(6):790-792Egevad L; Strom P; Kartasalo K; Olsson H; Samaratunga H; Delahunt B; Eklund M
- Preprint: ARXIV. 2020Ström P; Kartasalo K; Ruusuvuori P; Grönberg H; Samaratunga H; Delahunt B; Tsuzuki T; Egevad L; Eklund M
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)Lantz A; Olsson H; Nordstrom T; Jaderling F; Egevad L; Annerstedt M; Gronberg H; Eklund M
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)Nordstrom T; Discacciati A; Jaderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
- Preprint: RESEARCH SQUARE. 2020Crippa A; De Laere B; Discacciati A; Larsson B; Connor JT; Gabriel EE; Thellenberg C; Jänes E; Enblad G; Ullen A; Hjälm-Eriksson M; Oldenburg J; Ost P; Lindberg J; Eklund M; Grönberg H
- Conference publication: CANCER RESEARCH. 2020;80(4):ot3-03-02-ot3-03-02Che M; Fiscallini AS; Acerbi I; Shieh Y; Madlensky L; Tice J; Ziv E; Eklund M; Blanco A; Tong B; Goodman D; Nassereddine L; Anderson N; Harvey H; Fors S; Park HL; Petruse A; Stewart S; Wernisch J; Risty L; Hurley I; Koenig B; Kaplan C; Hiatt R; Wenger N; Lee V; Heditsian D; Brain S; Sabacan L; Parker B; Borowsky A; Anton-Culver H; Anton-Culver H; Naeim A; Kaster A; Talley M; van't Veer L; LaCroix A; Olopade OI; Sheth D; Esserman L
- Preprint: SSRN ELECTRONIC JOURNAL. 2020Morgantini L; Naha U; Wang H; Francavilla S; Acar Ö; Flores JM; Crivellaro S; Moreira D; Abern M; Eklund M; Vigneswaran HT; Weine SM
- Letter: NPJ DIGITAL MEDICINE. 2019;2:101Eklund M; Kartasalo K; Olsson H; Strom P
- Conference publication: ANNALS OF ONCOLOGY. 2019;30:354Lindberg J; De Laere B; Crippa A; Eklund M; Gronberg H
- Conference publication: ANNALS OF ONCOLOGY. 2019;30De Laere B; Crippa A; Ghysel C; Ost P; Rajan P; Eklund M; Dirix L; Gronberg H; Lindberg J
- Preprint: ARXIV. 2019Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan C-C; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Bergström C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
- Conference publication: CANCER RESEARCH. 2019;79(13):3361Karlsson A; Shieh Y; Dempsey A; Yau C; Dmichele A; Yes D; van't Veer L; Hylton N; Eklund M; Esserman L
- Conference publication: 2019;:3361Karlsson A; Shieh Y; Dempsey A; Yau C; Dmichele A; Yes D; Veer LV; Hylton N; Eklund M; Esserman L
- Letter: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2019;111(7):748Strom P; Lantz AW; Gronberg H; Nordstrom T; Eklund M
- Letter: EUROPEAN UROLOGY. 2019;75(4):e104-e105Eklund M; Strom P; Gronberg H; Nordstrom T
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(7):48Andersson JM; Nordstrom T; Eklund M; Gronberg H
- Letter: HUMAN GENETICS. 2019;138(3):287-289Antoniou A; Anton-Culver H; Borowsky A; Broeders M; Brooks J; Chiarelli A; Chiquette J; Cuzick J; Delaloge S; Devilee P; Dorval M; Easton D; Eisen A; Eklund M; Eloy L; Esserman L; Garcia-Closas M; Goldgar D; Hall P; Knoppers BM; Kraft P; La Croix A; Madalensky L; Mavaddat N; Mittman N; Nabi H; Olopade O; Pashayan N; Schmidt M; Shieh Y; Simard J; Stover-Fiscallini A; Tice JA; van't Veer L; Wenger N; Wolfson M; Yau C; Ziv E
- Conference publication: CANCER RESEARCH. 2019;79(4):p4-09-03-p4-09-03Shieh Y; Esserman L; Eklund M
- Conference publication: CANCER RESEARCH. 2019;79(4):ot2-08-01-ot2-08-01Acerbi I; Shieh Y; Madlensky L; Tice J; Ziv E; Eklund M; Blanco A; DeRosa D; Tong B; Goodman D; Nassereddine L; Anderson N; Harvey H; Layton T; Park HL; Petruse A; Stewart S; Wernisch J; Risty L; Koenig B; Sarrafan S; Firouzian R; Kaplan C; Hiatt R; Parker BA; Wenger N; Lee V; Heditsian D; Brain S; Fiscalini AS; Borowsky AD; Anton-Culver H; Naeim A; Kaster A; Talley M; Van 't Veer LJ; LaCroix A; Esserman LJ
- Corrigendum: NATURE GENETICS. 2019;51(2):363Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Amos CI; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA
- Corrigendum: NATURE COMMUNICATIONS. 2019;10(1):382Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Al Olama AA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu Y-J; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw K-T; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA; Henderson BE; Stern MC; Thwaites A; Guy M; Whitmore I; Morgan A; Fisher C; Hazel S; Livni N; Cook M; Fachal L; Weinstein S; Freeman LEB; Hoover RN; Machiela MJ; Lophatananon A; Carter BD; Goodman P; Moya L; Srinivasan S; Kedda M-A; Yeadon T; Eckert A; Eklund M; Cavalli-Bjoerkman C; Dunning AM; Sipeky C; Hakansson N; Elliott R; Ranu H; Giovannucci E; Turman C; Hunter DJ; Cussenot O; Orntoft TF; Lane A; Lewis SJ; Davis M; Key TJ; Brown P; Kulkarni GS; Zlotta AR; Fleshner NE; Finelli A; Mao X; Marzec J; MacInnis RJ; Milne R; Hopper JL; Aguado M; Bustamante M; Castano-Vinyals G; Gracia-Lavedan E; Cecchini L; Stampfer M; Ma J; Sellers TA; Geybels MS; Park H; Zachariah B; Kolb S; Wokolorczyk D; Lubinski J; Kluzniak W; Nielsen SF; Weisher M; Cuk K; Vogel W; Luedeke M; Logothetis CJ; Paulo P; Cardoso M; Maia S; Silva MP; Steele L; Ding YC; De Meerleer G; De Langhe S; Thierens H; Lim J; Tan MH; Ong AT; Lin DW; Kachakova D; Mitkova A; Mitev V; Parliament M; Jenster G; Bangma C; Schroder FH; Truong T; Koudou YA; Michael A; Kierzek A; Karlsson A; Broms M; Wu H; Aukim-Hastie C; Tillmans L; Riska S; McDonnell SK; Dearnaley D; Spurdle A; Gardiner R; Hayes V; Butler L; Taylor R; Papargiris M; Saunders P; Kujala P; Talala K; Taari K; Bentzen S; Hicks B; Vogt A; Hutchinson A; Cox A; George A; Toi A; Evans A; van der Kwast TH; Imai T; Saito S; Zhao S-C; Ren G; Zhang Y; Yu Y; Wu Y; Wu J; Zhou B; Pedersen J; Lobato-Busto R; Manuel Ruiz-Dominguez J; Mengual L; Alcaraz A; Pow-Sang J; Herkommer K; Vlahova A; Dikov T; Christova S; Carracedo A; Tretarre B; Rebillard X; Mulot C; Adolfsson J; Stattin P; Johansson J-E; Martin RM; Thompson IMJ; Chambers S; Aitken J; Horvath L; Haynes A-M; Tilley W; Risbridger G; Aly M; Nordstrom T; Pharoah P; Tammela TLJ; Murtola T; Auvinen A; Burnet N; Barnett G; Andriole G; Klim A; Drake BF; Borre M; Kerns S; Ostrer H; Zhang H-W; Cao G; Lin J; Ling J; Li M; Feng N; Li J; He W; Guo X; Sun Z; Wang G; Guo J; Southey MC; FitzGerald LM; Marsden G; Gomez-Caamano A; Carballo A; Peleteiro P; Calvo P; Szulkin R; Llorca J; Dierssen-Sotos T; Gomez-Acebo I; Lin H-Y; Ostrander EA; Bisbjerg R; Klarskov P; Roder MA; Iversen P; Holleczek B; Stegmaier C; Schnoeller T; Bohnert P; John EM; Ost P; Teo S-H; Gamulin M; Kulis T; Kastelan Z; Slavov C; Popov E; Van den Broeck T; Joniau S; Larkin S; Esteban Castelao J; Martinez ME; van Schaik RHN; Xu J; Lindstrom S; Riboli E; Berry C; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Freedman M; Cenee S; Sanchez M
- Editorial comment: EUROPEAN UROLOGY. 2018;74(6):739-740Nordstrom T; Lindberg J; Eklund M
- Preprint: BIORXIV. 2018Karlsson A; Jauhiainen A; Gulati R; Eklund M; Grönberg H; Etzioni R; Clements M
- Letter: EUROPEAN UROLOGY. 2018;74(2):e35-e36Vickers A; Nordstrom T; Assel M; Lilja H; Gronberg H; Eklund M
- Letter: EUROPEAN UROLOGY. 2018;74(1):e10-e11Eklund M; Strom P; Nordstrom T; Gronberg H
- Conference publication: JOURNAL OF GENERAL INTERNAL MEDICINE. 2018;33:S143-S144Shieh Y; Ziv E; Eklund M; Madlensky L; Blanco A; Acerbi I; Fiscalini AS; Anton-Culver H; Borowsky A; LaCroix A; Naeim A; Parker B; van't Veer L; Esserman LJ
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(6):tps397Gronberg H; Eklund M; Lindberg J; Ullen A; Bjartell A; Andren O; Robinson D; Lissbrant IF; Enblad G; Stahl O; Thellenberg C
- Conference publication: CANCER RESEARCH. 2018;78(4)Wimmer K; Fiscalini AS; Eklund M; DiGiorgio K; Naeim A; Esserman L
- Conference publication: CANCER RESEARCH. 2018;78(4)Shieh Y; Ziv E; Eklund M; Sabacan L; Firouzian R; Madlensky L; Anton-Culver H; Borowsky A; LaCroix A; Naeim A; Parker B; van't Veer L; Esserman L; Tice J
- Editorial comment: EUROPEAN UROLOGY FOCUS. 2017;3(6):526-528Nordstrom T; Picker W; Aly M; Jaderling F; Adolfsson J; Strom P; Haug ES; Eklund M; Carlsson S; Gronberg H
- Other: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2017;35(3):120Scott E; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
- Letter: NATURE REVIEWS CLINICAL ONCOLOGY. 2016;13(6):395-U82Eklund M; Gronberg H; Nordstrom T
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):e18281Rosenberg-Wohl S; Narasimmaraj P; Fiscalini AS; DiGiorgio K; Latts L; Thygeson M; Eklund M; Connor J; Broglio K; Tice J; Kramer M; LaCroix A; Hiatt RA; Parker BA; Layton TM; Esserman L
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):tps1594Rosenberg-Wohl S; Eklund M; Tice J; Ziv E; Kaplan C; Van't Veer L; LaCroix A; Madlensky L; Naeim A; Wenger N; Borowsky AD; Fenton J; Anton-Culver H; Hogarth M; Cink T; Brain S; Heditsian D; Lee V; Fiscalini AS; Esserman L
- Conference publication: CANCER RESEARCH. 2016;76:p6-02-08-p6-02-08Thompson CK; Fiscalini AS; Donnellan P; Kaplan CP; Madlensky L; Eklund M; Ziv E; van't Veer LJ; Tice JA; Esserman LJ
- Editorial comment: BMJ-BRITISH MEDICAL JOURNAL. 2016;352:i551Shieh Y; Eklund M; Esserman L
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(2):284Nordstrom T; Adolfsson J; Gronberg H; Eklund M
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(2):36Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
- Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2015;51:S167-S168Holm J; Li J; Darabi H; Eklund M; Eriksson M; Humphreys K; Hall P; Czene K
- Conference publication: CANCER RESEARCH. 2015;75(9_Supplement):p3-02-01-p3-02-01Thompson CK; O'Donoghue C; Ozanne EM; Eklund M; Esserman LJ
- Letter: ANNALS OF INTERNAL MEDICINE. 2014;161(4):305Eklund M; O'Donoghue C; Esserman LJ
- Book chapter: PROGRESS IN PATTERN RECOGNITION, IMAGE ANALYSIS, COMPUTER VISION, AND APPLICATIONS: IFIP ADVANCES IN INFORMATION AND COMMUNICATION TECHNOLOGY. 2014;p. 231-240Carlsson L; Eklund M; Norinder U
- Editorial comment: NATURE REVIEWS CLINICAL ONCOLOGY. 2013;10(12):673-675Eklund M; Esserman LJ
- Conference publication: CANCER RESEARCH. 2012;72:p3-02-12-p3-02-12Thorsen CM; Eklund M; Ozanne EM; Esserman LJ
- Corrigendum: MOLECULAR INFORMATICS. 2012;31(10):752Eklund M; Norinder U; Boyer S; Carlsson L
- Review: CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2012;12(18):1980-1986Spjuth O; Carlsson L; Alvarsson J; Georgiev V; Willighagen E; Eklund M
- Meeting abstract: TOXICOLOGY LETTERS. 2012;211:S62Carlsson L; Spjuth O; Eklund M; Boyer S
- Book chapter: ARTIFICIAL INTELLIGENCE APPLICATIONS AND INNOVATIONS: IFIP ADVANCES IN INFORMATION AND COMMUNICATION TECHNOLOGY. 2012;p. 166-175Eklund M; Norinder U; Boyer S; Carlsson L
- Book chapter: COMPUTATIONAL APPROACHES IN CHEMINFORMATICS AND BIOINFORMATICS. 2011;p. 57-92Wikberg JES; Spjuth O; Eklund M; Lapins M
- Show more
Grants
- Swedish Research Council1 January 2023 - 31 December 2025Prostate cancer is a leading cause of cancer-related death in males. Prostate cancer screening every 2-4 year has been shown to decrease prostate-cancer mortality and opportunistic screening is wide-spread. In a recent high-impact project, we showed that screening-related over-diagnosis at an initial screen can be mitigated and screening outcomes improved by using magnetic resonance imaging (MRI), novel blood-based risk prediction and targeted biopsies (STHLM3MRI: Eklund et al NEJM 2021Nordström et al Lancet Onc 2021). There are ongoing initiatives for implementing screening, but there are important knowledge gaps on how to design repeat screening, screening interventions and the real-world performance of screening outside trials.The purpose of this project is to provide unique evidence on re-screen methods by completing three work packages (WP) within a three year timeframe. This includes a prospective paired design study on repeat prostate cancer screening (WP1), studies on optimization of screening interventions (WP2) using retrospective, screen-by-invitation data from the STHLM3MRI project and building a collaborative platform for assessment of real-world outcomes inside and outside a screening program initiative (WP3).Our studies provide vital data on optimal screening intervals and interventions (MRI, biopsy decision aids and biopsy strategies) as well as knowledge on acceptance and performance of prostate cancer screening.
- Swedish Research Council1 January 2023 - 31 December 2025Our general aim is to use modelling to reduce the burden due to prostate and cervical cancer through cost-effective screening. For prostate cancer, new tests, magnetic resonance imaging (MRI) and artificial intelligence (AI) assisted pathology are expected to reduce harms while maintaining the mortality benefits from early detection. For cervical cancer, human papillomavirus (HPV) vaccinations are expected to substantially reduce HPV incidence and eventually lead to the eradication of cervical cancer. With changes to HPV transmission, cervical cancer screening may require extended genotyping, self-sampling and renewed guidelines to be cost-effective.We will evaluate the cost-effectiveness of: (i) organised prostate cancer testing (OPT) in Sweden, including MRI and the Stockholm3 test(ii) prostate cancer testing using a genetic risk score(iii) prostate cancer diagnostics using AI-assisted pathologyand (iv) primary HPV testing with extended genotyping in vaccinated cohorts with clinic-based testing or self-sampling. These results will inform policy for (a) the development and planning of a national OPT program, (b) the use of AI-assisted histopathology, and (c) the development of national cervical cancer screening guidelines for vaccinated cohorts.
- Swedish Cancer Society1 January 2022Prostate cancer is the most common form of cancer and the leading cause of cancer death among men in Sweden. In 2018, over 10,000 men were diagnosed with prostate cancer and 2,350 died from the disease. A bottleneck in the effort to reduce prostate cancer mortality is the difficulty in making objective and reproducible pathological assessments of tissue samples (biopsies) from the prostate. Histopathological evaluation of prostate biopsies is used to diagnose the disease and grade its severity, and is of crucial importance for the clinical management and treatment of men diagnosed with prostate cancer. Despite the importance of histopathological assessment of prostate biopsies, there are major challenges. The so-called Gleason grade is crucial for treatment decisions for men diagnosed with prostate cancer. As the Gleason grade often differs between different pathologists' assessments, treatment decisions can be made on incorrect information about the severity of the disease. This can lead to the man not receiving sufficiently aggressive treatment or receiving unnecessarily aggressive treatment. My research group has developed a system based on artificial intelligence (AI) to assist the pathologists, with the overall goal of solving these challenges. In the proposed research, we will continue the development of the AI system, link it to genomic information from the tissue samples, and conduct rigorous clinical validation of the system through a network of international collaborators and through a randomized clinical trial. The overall aim of the research is to make prostate cancer diagnosis more accurate, in order to provide better information to make correct treatment decisions for men diagnosed with prostate cancer and thus achieve better treatment results and fewer side effects of the treatment.
- Swedish Research Council1 January 2022 - 31 December 2025The lack of treatment-predictive biomarkers is an unmet clinical need in metastatic prostate cancer leading to inferior clinical outcomes, overtreatment and accelerating costs. The ProBio study (NCT03903835) is an ongoing randomized trial that builds on a novel adaptive study design and prospectively evaluates treatment predictive biomarker signatures in a large network of over 35 study centers in Europe. By using ProBio we will be able to rapidly evaluate both new and old drugs in subsets of patients with similar genomic biomarker. If successful, patients with prostate cancer will get individualized treatment based on treatment-predictive genomic biomarker signatures in the near future.To test this hypothesis, we will use a multiphase randomized study using an outcome-adaptive multi-arm biomarker-driven study design. We have the following main aims: To investigate if treatment decisions based on a biomarker signature identified by sequencing circulating tumor DNA improves progression free survival (primary endpoint)To ultimately show that the ProBio concept is a model for collaboration between academia and industry in the evaluation of new drugs in prostate cancer
- Swedish Research Council1 January 2021 - 31 December 2026Histopathological evaluation of prostate biopsies is critical to the clinical management of men suspected of having prostate cancer. Despite this importance, the histopathological diagnosis of prostate cancer is associated with a number of challenges: The large number of prostate biopsies being performed worldwide together with the shortage of well-trained uro-pathologists and the high inter- pathologist variability leads to suboptimal prostate cancer diagnostics and prognostication, with risks for under- and overtreatment.My research group has over the last years developed an artificial intelligence (AI) system to assist the pathologists in the evaluation of prostate biopsies, with the overarching aim of solving these problems. In a recent article in the Lancet Oncology, we demonstrate that the system performs on par with internationally leading uro-pathologist for grading prostate needle biopsies.In this research proposal, we aim to:Perform retrospective international multisite validation of the AI system to assess the AI’s performance across different labs, technical platforms (scanners), and disease subtypesDevelop methods to go beyond today’s grading to improve prognosticationLink the AI system with genomic profiling of tumor tissue to improve treatment selectionPerform prospective validation of the AI system in a randomized diagnostic histopathology trial
- Swedish Research Council1 January 2021 - 31 December 2024
- Swedish Research Council1 January 2020 - 31 December 2023
- Swedish Research Council1 January 2019 - 31 December 2022
- Improved active monitoring of patients with diagnosed low-risk prostate cancerSwedish Cancer Society1 January 2018More than 2,500 men die each year from prostate cancer in Sweden. Although PSA sampling every two years between ages 50 and 70 has been shown to nearly halve mortality, PSA has significant diagnostic limitations leading to many unnecessary biopsies, over-diagnosis, and over-treatment, which is why prostate cancer screening is not recommended by healthcare. The need for improved methods for early detection of prostate cancer is thus great. In recent years, we have conducted the SHLM3 studies, where we show that we can significantly improve prostate cancer diagnosis using the STHLM3 test and the use of magnetic camera studies. Active monitoring of men with diagnosed low-risk prostate cancer is a method for reducing over-treatment, which involves following up the patient with repeated PSA tests and biopsies to be able to subsequently distinguish those who need to be treated. One disadvantage of active monitoring is the many biopsies that men are exposed to, which can lead to serious infections and impaired opportunities for effective surgery if active treatment is needed. We want to develop methods for monitoring low-risk patients who are safe and less invasive using the STHLM3 test and magnetic camera surveys. The research aims to improve the methods for active monitoring in order to reduce the negative consequences of early diagnostics for prostate cancer. Considering that over-diagnosis and over-treatment were the main reason why prostate cancer screening was not recommended, improved methods of managing mites that are diagnosed with low-risk prostate cancers are required so that we can move towards effective organized screening for prostate cancer to reduce morbidity and mortality in Sweden's most deadly cancer.
- Swedish Research Council1 January 2018 - 31 December 2020
- Swedish Research Council1 December 2017 - 31 December 2020
- Risk-based screening for prostate cancerSwedish Cancer Society1 January 2017More than 2,500 men die each year from prostate cancer in Sweden. Although PSA sampling every two years between ages 50 and 70 has been shown to nearly halve mortality, PSA has significant diagnostic limitations leading to many unnecessary biopsies, over-diagnosis, and over-treatment, which is why prostate cancer screening is not recommended by healthcare. The need for improved methods for early detection of prostate cancer is thus great. In recent years, we have conducted STHLM3, a study of 59,000 participants in Stockholm, where we show that we can significantly improve prostate cancer diagnosis using the risk-based STHLM test. STHLM3 is a step towards an organized, individualized and risk-based test program for prostate cancer. However, several questions remain to be answered in order to optimally use the results from STHLM3: (i) Between which ages and how often should men be tested? (ii) How should the results of STHLM3 be used after an initial negative biopsy? (iii) How should the results be used together with magnetic resonance camera surveys to further improve the test? The research in this application focuses on answering the first of these questions. Prostate cancer screening is emotionally charged and highly stained by over-diagnosis and over-treatment. The proposed research will reduce the negative consequences of prostate cancer screening without compromising the positive effects of reduced mortality. We now have the opportunity to move away from the current opportunistic screening situation in Sweden and instead construct a strategy that maximizes the benefit of the screening and utilizes the great research-related advances in risk assessment in the right way to reduce the mortality in prostate cancer.
- Risk-based screening for prostate cancerSwedish Cancer Society1 January 2016More than 2,500 men die each year from prostate cancer in Sweden. Although PSA sampling every two years between ages 50 and 70 has been shown to nearly halve mortality, PSA has significant diagnostic limitations leading to many unnecessary biopsies, over-diagnosis, and over-treatment, which is why prostate cancer screening is not recommended by healthcare. The need for improved methods for early detection of prostate cancer is thus great. In recent years, we have conducted STHLM3, a study of 59,000 participants in Stockholm, where we show that we can significantly improve prostate cancer diagnosis using the risk-based STHLM test. STHLM3 is a step towards an organized, individualized and risk-based test program for prostate cancer. However, several questions remain to be answered in order to optimally use the results from STHLM3: (i) Between which ages and how often should men be tested? (ii) How should the results of STHLM3 be used after an initial negative biopsy? (iii) How should the results be used together with magnetic resonance camera surveys to further improve the test? The research in this application focuses on answering the first of these questions. Prostate cancer screening is emotionally charged and highly stained by over-diagnosis and over-treatment. The proposed research will reduce the negative consequences of prostate cancer screening without compromising the positive effects of reduced mortality. We now have the opportunity to move away from the current opportunistic screening situation in Sweden and instead construct a strategy that maximizes the benefit of the screening and utilizes the great research-related advances in risk assessment in the right way to reduce the mortality in prostate cancer.
- Swedish Research Council for Health Working Life and Welfare1 January 2016 - 31 December 2018
- Risk-based screening for prostate cancerSwedish Cancer Society1 January 2015More than 2,500 men die each year from prostate cancer in Sweden. Although PSA sampling every two years between ages 50 and 70 has been shown to nearly halve mortality, PSA has significant diagnostic limitations leading to many unnecessary biopsies, over-diagnosis, and over-treatment, which is why prostate cancer screening is not recommended by healthcare. The need for improved methods for early detection of prostate cancer is thus great. In recent years, we have conducted STHLM3, a study of 59,000 participants in Stockholm, where we show that we can significantly improve prostate cancer diagnosis using the risk-based STHLM test. STHLM3 is a step towards an organized, individualized and risk-based test program for prostate cancer. However, several questions remain to be answered in order to optimally use the results from STHLM3: (i) Between which ages and how often should men be tested? (ii) How should the results of STHLM3 be used after an initial negative biopsy? (iii) How should the results be used together with magnetic resonance camera surveys to further improve the test? The research in this application focuses on answering the first of these questions. Prostate cancer screening is emotionally charged and highly stained by over-diagnosis and over-treatment. The proposed research will reduce the negative consequences of prostate cancer screening without compromising the positive effects of reduced mortality. We now have the opportunity to move away from the current opportunistic screening situation in Sweden and instead construct a strategy that maximizes the benefit of the screening and utilizes the great research-related advances in risk assessment in the right way to reduce the mortality in prostate cancer.
- Swedish Research Council for Health Working Life and Welfare1 November 2012 - 31 October 2015
Employments
- Professor, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2022-
Degrees and Education
- Docent, Karolinska Institutet, 2013
- PhD Biostatistics, Uppsala University, 2010
- MSc Mathematics, Uppsala University, 2006
- MSc Molecular Biotechnology (civilingenjör), , Uppsala University, 2005
- BSc Macroeconomics, Uppsala University, 2004